{
  "meta": {
    "title": "18_Hepatitis",
    "url": "https://brainandscalpel.vercel.app/18-hepatitis-261fa9d4.html",
    "scrapedAt": "2025-11-30T06:57:51.130Z"
  },
  "questions": [
    {
      "id": 96929,
      "choices": [
        {
          "id": 212068,
          "text": "Hepatitis A"
        },
        {
          "id": 212069,
          "text": "Hepatitis B"
        },
        {
          "id": 212070,
          "text": "Hepatitis D"
        },
        {
          "id": 212071,
          "text": "Hepatitis E"
        }
      ],
      "text": "Which of the following hepatitis virus is cultivable?",
      "unique_key": "Q1509810",
      "question_audio": null,
      "question_video": null,
      "map_id": 34868173,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hepatitis A virus (HAV) because Hepatitis A is the only cultivable hepatitis virus. HAV, a non-enveloped, positive-sense single-stranded RNA virus from the Picornaviridae family, can be grown in primary monkey kidney cells, fetal rhesus monkey kidney cells, and other human cell lines. This has allowed scientists to study the virus in laboratory settings and develop effective vaccines. HAV is primarily transmitted via the fecal-oral route, causing acute hepatitis, but it does not lead to chronic liver disease. Since it can be propagated in cell culture, it is used in laboratory research and vaccine production. Explanation of Incorrect Options: (B) Hepatitis B – Incorrect Hepatitis B virus (HBV) is a DNA virus from the Hepadnaviridae family and cannot be cultivated in vitro using standard cell culture techniques. Instead, HBV requires hepatic cells within living organisms (such as chimpanzees and transgenic mice) to replicate efficiently. Research is often conducted using recombinant systems or hepatocyte cultures, but the virus itself is not cultivable in routine lab settings. (C) Hepatitis D – Incorrect Hepatitis D virus (HDV) is a defective RNA virus that depends on Hepatitis B virus (HBV) for replication, as it requires HBsAg (Hepatitis B surface antigen) to assemble. Since HDV cannot replicate independently and does not grow in standard cell culture, it is not cultivable. (D) Hepatitis E – Incorrect Hepatitis E virus (HEV) is a non-enveloped RNA virus from the Hepeviridae family, primarily transmitted via the fecal-oral route. While limited research has been conducted on growing HEV in specific cell lines, it is generally not considered cultivable in standard laboratory settings. Most HEV studies rely on animal models and recombinant viral proteins rather than direct cell culture propagation.",
      "correct_choice_id": 212068,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43772751700916172/43772751700916172.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43772751700916172/43772751700916172.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96930,
      "choices": [
        {
          "id": 212072,
          "text": "IgM Anti-HBc antibody"
        },
        {
          "id": 212073,
          "text": "HbeAg"
        },
        {
          "id": 212074,
          "text": "HBV DNA by PCR"
        },
        {
          "id": 212075,
          "text": "Anti-HBc antibody"
        }
      ],
      "text": "A 30 years old patient presented with history of jaundice for 10 days. His liver function tests showed biliru¬bin of 10 mg/dl, SGOT/SGPT - 1100/1450, serum alkaline phosphatase-240 IU. He was positive for HbsAg. What should be the confirmatory test to establish acute hepatitis B infection?",
      "unique_key": "Q5727241",
      "question_audio": null,
      "question_video": null,
      "map_id": 34417203,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) IgM Anti-HBc antibody, as it is the most reliable marker for acute Hepatitis B virus (HBV) infection. IgM anti-HBc (Immunoglobulin M antibody to hepatitis B core antigen) appears early in acute hepatitis B and is the best serological marker to distinguish acute from chronic infection. It is present during the symptomatic phase of infection, including during the window period when HBsAg (Hepatitis B surface antigen) disappears but before Anti-HBs (antibodies against HBsAg) develop. Since the patient has elevated bilirubin, SGOT, SGPT levels, and is HBsAg positive, it is crucial to confirm whether this is an acute or chronic HBV infection. IgM anti-HBc positivity confirms an acute or recent HBV infection, whereas IgG anti-HBc (which appears later) indicates a past or chronic infection. Explanation of Incorrect Options: (B) HBeAg – Incorrect HBeAg (Hepatitis B e-antigen) is a marker of active viral replication and infectivity. While it suggests a high viral load, it does not confirm whether the infection is acute or chronic. Some chronic carriers also test positive for HBeAg, so it is not the best diagnostic test for acute hepatitis B. (C) HBV DNA by PCR – Incorrect HBV DNA PCR detects viral load and confirms HBV infection, but it does not differentiate acute from chronic infection. It is primarily used to assess viral replication and treatment response rather than establish the acute phase of HBV. (D) Anti-HBc antibody – Incorrect This option is nonspecific because it does not specify IgM or IgG. Total Anti-HBc (IgM + IgG) remains positive for life in both acute and chronic hepatitis B infections. Only IgM anti-HBc is specific for acute infection, making option (A) the correct choice.",
      "correct_choice_id": 212072,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62911831700916186/62911831700916186.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62911831700916186/62911831700916186.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96931,
      "choices": [
        {
          "id": 212076,
          "text": "Both active and passive immunization soon after birth"
        },
        {
          "id": 212077,
          "text": "Passive immunization soon after birth and active im¬munization at 1 year of age"
        },
        {
          "id": 212078,
          "text": "Only passive immunization soon after birth"
        },
        {
          "id": 212079,
          "text": "Only active immunization soon after birth"
        }
      ],
      "text": "A 30 years old lady delivered a healthy baby at 37 weeks of gestation. She was a known case of chronic hepatitis B infection. She was positive for HBsAg but negative for HBeAg. Which of the following is the most appropriate treatment for the baby?",
      "unique_key": "Q3510387",
      "question_audio": null,
      "question_video": null,
      "map_id": 34749194,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Both active and passive immunization soon after birth because this approach provides the best protection against perinatal transmission of hepatitis B virus (HBV). Newborns born to mothers who are HBsAg positive (regardless of HBeAg status) are at high risk of developing chronic HBV infection, especially since neonatal immune systems are immature. To prevent infection, the recommended protocol is: Passive Immunization: Hepatitis B Immunoglobulin (HBIG) should be given within 12 hours of birth to provide immediate protection by neutralizing the virus. Active Immunization: Hepatitis B vaccine should also be administered within 12 hours of birth, followed by additional doses at 1 and 6 months of age for long-term immunity. This combination of active and passive immunization has been shown to reduce the risk of perinatal HBV transmission by over 90%, even if the mother is highly infectious. Explanation of Incorrect Options: (B) Passive immunization soon after birth and active immunization at 1 year of age – Incorrect Delaying active immunization until 1 year of age is not recommended because HBV can establish chronic infection quickly in neonates. Without timely vaccination, the baby remains vulnerable to infection. (C) Only passive immunization soon after birth – Incorrect HBIG alone provides temporary protection but does not induce long-term immunity. Without the Hepatitis B vaccine, the baby remains at risk of HBV infection once the passive antibodies wane. (D) Only active immunization soon after birth – Incorrect The Hepatitis B vaccine alone takes time to stimulate an immune response. In high-risk infants, the window period before immunity develops is critical, making HBIG necessary for immediate protection.",
      "correct_choice_id": 212076,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35331851700916198/35331851700916198.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35331851700916198/35331851700916198.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96932,
      "choices": [
        {
          "id": 212080,
          "text": "Chronic hepatitis B infection with high infectivity"
        },
        {
          "id": 212081,
          "text": "Acute hepatitis B infection with high infectivity"
        },
        {
          "id": 212082,
          "text": "Chronic hepatitis B infection with low infectivity"
        },
        {
          "id": 212083,
          "text": "Acute hepatitis B infection with low infectivity"
        }
      ],
      "text": "A 30 years man presented with nausea, fever and jaundice of 5 days duration. The biochemical tests revealed a bilirubin of 6.7 mg/dl (conjugated 5.0 mg/dl) with SGOT/SGPT (AST/ALT) of 1230/900 IU/ml. The serological tests showed presence of HBs Ag ,IgM anti-HBc and HBeAg. The most likely diagnosis:",
      "unique_key": "Q1884875",
      "question_audio": null,
      "question_video": null,
      "map_id": 34645083,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Acute hepatitis B infection with high infectivity because the presence of IgM anti-HBc, HBsAg, and HBeAg strongly suggests acute HBV infection with a high level of viral replication and infectivity. IgM anti-HBc (Immunoglobulin M against Hepatitis B core antigen) is a marker of acute infection, appearing early and disappearing within 6 months. HBsAg (Hepatitis B surface antigen) indicates HBV infection, but does not differentiate between acute and chronic stages. HBeAg (Hepatitis B e antigen) is associated with active viral replication and high infectivity, meaning the patient can easily transmit the virus. Significantly elevated AST/ALT levels (SGOT/SGPT: 1230/900 IU/ml) indicate acute hepatocellular injury, which is characteristic of acute hepatitis B infection. Thus, the combination of IgM anti-HBc, HBsAg, and HBeAg confirms that this is an acute infection rather than a chronic one, and the presence of HBeAg indicates high infectivity. Explanation of Incorrect Options: (A) Chronic hepatitis B infection with high infectivity – Incorrect Chronic HBV infection is characterized by the persistence of HBsAg for more than 6 months. In chronic cases, IgM anti-HBc is typically absent or present in low levels, while IgG anti-HBc dominates. This patient has IgM anti-HBc, confirming an acute infection. (C) Chronic hepatitis B infection with low infectivity – Incorrect If the infection were chronic with low infectivity, we would expect HBeAg to be negative and anti-HBe to be positive (suggesting seroconversion and a lower viral replication rate). However, this patient has HBeAg positivity, indicating high viral replication. (D) Acute hepatitis B infection with low infectivity – Incorrect An acute infection with low infectivity would show IgM anti-HBc and HBsAg, but HBeAg would be negative, replaced by anti-HBe. Since this patient has HBeAg positivity, it confirms high infectivity.",
      "correct_choice_id": 212081,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8070931700916210/8070931700916210.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8070931700916210/8070931700916210.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96933,
      "choices": [
        {
          "id": 212084,
          "text": "Hepatitis B vaccine + immunoglobulins"
        },
        {
          "id": 212085,
          "text": "Immunoglobulins only"
        },
        {
          "id": 212086,
          "text": "Hepatitis B vaccine only"
        },
        {
          "id": 212087,
          "text": "Immunoglobulins followed by vaccine 1 month later"
        }
      ],
      "text": "A mother is HBsAg positive at 32 weeks of pregnancy. What should be given to the newborn to prevent neonatal infection:",
      "unique_key": "Q8668124",
      "question_audio": null,
      "question_video": null,
      "map_id": 34847554,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hepatitis B vaccine + immunoglobulins because both active and passive immunization are required to prevent neonatal hepatitis B virus (HBV) infection in newborns of HBsAg-positive mothers. Hepatitis B immunoglobulin (HBIG) provides immediate passive immunity by neutralizing the virus, reducing the risk of transmission from mother to child. Hepatitis B vaccine provides long-term active immunity by stimulating the baby’s immune system to produce protective antibodies. Both HBIG and the first dose of the hepatitis B vaccine should be given within 12 hours of birth for maximum effectiveness. This combined approach is highly effective in preventing vertical transmission of HBV from an infected mother to her newborn. Explanation of Incorrect Options: (B) Immunoglobulins only – Incorrect While HBIG provides temporary protection, it does not induce long-term immunity. Without the hepatitis B vaccine, the baby remains at risk of future HBV infection. (C) Hepatitis B vaccine only – Incorrect The vaccine induces active immunity, but it takes time for the immune response to develop. Without HBIG, the baby remains at risk of early HBV infection, especially from exposure during birth. (D) Immunoglobulins followed by vaccine 1 month later – Incorrect Delaying the hepatitis B vaccine by one month increases the risk of perinatal transmission. The vaccine should be given at birth, along with HBIG, to provide immediate and long-term protection.",
      "correct_choice_id": 212084,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73101711700916221/73101711700916221.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73101711700916221/73101711700916221.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96934,
      "choices": [
        {
          "id": 212088,
          "text": "HBsAg"
        },
        {
          "id": 212089,
          "text": "Anti-HBs Ag"
        },
        {
          "id": 212090,
          "text": "IgM Anti-HBc Ag and HBS Ag"
        },
        {
          "id": 212091,
          "text": "IgM and IgG Anti-HBc Ag"
        }
      ],
      "text": "Hepatitis B vaccination is given to a patient. His serum will reveal:",
      "unique_key": "Q1511452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34874013,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Anti-HBs Ag. Hepatitis B vaccination stimulates the immune system to produce antibodies against the Hepatitis B surface antigen (HBsAg). The vaccine itself contains HBsAg, but it does not introduce the live virus, meaning no actual infection occurs. As a result, after successful vaccination, the body produces anti-HBs antibodies, which indicate immunity to the virus. This is a protective response, and individuals with anti-HBs positivity (without any other markers of infection) are considered immune to Hepatitis B, either due to vaccination or past infection with subsequent recovery. Importantly, vaccinated individuals will not have other markers of Hepatitis B infection, such as HBsAg or anti-HBc antibodies, because the vaccine does not contain the viral core antigen (HBcAg). Explanation of Incorrect Options: (A) HBsAg – Incorrect. The presence of HBsAg (Hepatitis B surface antigen) in the serum indicates an active infection with Hepatitis B virus (HBV). However, the Hepatitis B vaccine does not cause an infection; it only triggers an immune response to generate anti-HBs antibodies. Therefore, a vaccinated person will have anti-HBs antibodies but not HBsAg in their serum. (C) IgM Anti-HBc Ag and HBs Ag – Incorrect. IgM anti-HBc (Hepatitis B core IgM antibody) is a marker of acute Hepatitis B infection and is not produced following vaccination. Similarly, as mentioned earlier, HBsAg appears only during an actual infection, not after vaccination. Since the vaccine does not contain the core antigen (HBcAg), it does not stimulate an anti-HBc response. (D) IgM and IgG Anti-HBc Ag – Incorrect. Both IgM and IgG anti-HBc antibodies are produced in response to natural HBV infection, not vaccination. IgM anti-HBc appears in the acute phase, while IgG anti-HBc remains after recovery or in chronic infection. Since the vaccine does not contain the core antigen (HBcAg), it does not induce any anti-HBc antibody response.",
      "correct_choice_id": 212089,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38465041700916232/38465041700916232.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38465041700916232/38465041700916232.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96935,
      "choices": [
        {
          "id": 212092,
          "text": "HBVDNA"
        },
        {
          "id": 212093,
          "text": "HBV DNA polymerase"
        },
        {
          "id": 212094,
          "text": "Anti-HBc"
        },
        {
          "id": 212095,
          "text": "AST and ALT"
        }
      ],
      "text": "Which of these is not a marker of active replicative phase of chronic hepatitis B?",
      "unique_key": "Q3072730",
      "question_audio": null,
      "question_video": null,
      "map_id": 34778650,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Anti-HBc. The presence of anti-HBc (Hepatitis B core antibody) does not indicate an active replicative phase of chronic Hepatitis B infection. Instead, anti-HBc antibodies (both IgM and IgG) indicate past or ongoing infection with HBV, but they do not directly reflect viral replication. IgM anti-HBc is typically found in acute infections, while IgG anti-HBc persists for life in both resolved and chronic infections. Because anti-HBc does not correlate with viral replication or activity, it is not a marker of the active replicative phase of chronic Hepatitis B. Explanation of Incorrect Options: (A) HBV DNA – Incorrect. HBV DNA is the most direct marker of active viral replication. The presence of HBV DNA in the serum indicates that the virus is replicating, and higher levels correlate with increased infectivity and disease activity in chronic Hepatitis B. (B) HBV DNA polymerase – Incorrect. HBV DNA polymerase is an enzyme responsible for viral replication, and its presence in the serum signifies active viral replication. It is considered an important marker of the replicative phase of HBV. (D) AST and ALT – Incorrect. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are liver enzymes that indicate liver cell injury. In the active replicative phase of chronic Hepatitis B, viral replication triggers liver inflammation, leading to elevated AST and ALT levels. While these enzymes do not specifically indicate viral replication, their rise correlates with disease activity and liver damage, often seen during the active phase of chronic Hepatitis B.",
      "correct_choice_id": 212094,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59803251700916246/59803251700916246.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59803251700916246/59803251700916246.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96936,
      "choices": [
        {
          "id": 212096,
          "text": "Vertical transmission is more important than horizontal"
        },
        {
          "id": 212097,
          "text": "Communicable period lasts for months"
        },
        {
          "id": 212098,
          "text": "Virus can be found in blood 1 month before jaundice"
        },
        {
          "id": 212099,
          "text": "Age of onset determines the prognosis"
        }
      ],
      "text": "About hepatitis B, false statement is:",
      "unique_key": "Q7570063",
      "question_audio": null,
      "question_video": null,
      "map_id": 34345133,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Vertical transmission is more important than horizontal transmission. This statement is false because horizontal transmission plays a more significant role in the spread of Hepatitis B globally, especially in endemic areas. While vertical transmission (mother-to-child transmission) is crucial in high-prevalence regions (such as East Asia and sub-Saharan Africa), horizontal transmission (through close contact, sexual contact, sharing needles, or blood transfusions) remains a major mode of HBV spread worldwide. In many cases, horizontal transmission in early childhood is a major driver of chronic infections, particularly in intermediate-prevalence regions. Thus, while both modes are important, horizontal transmission is generally more significant in global HBV spread. Explanation of Incorrect Options: (B) Communicable period lasts for months – Incorrect. This statement is true because individuals with acute or chronic HBV infection can remain contagious for several months or even years. In acute Hepatitis B, the virus can be transmitted from several weeks before symptoms appear and continues to be communicable for months. In chronic infection, the virus remains in the body indefinitely, making infected individuals potentially contagious for life if HBsAg remains positive. (C) Virus can be found in blood 1 month before jaundice – Incorrect. This statement is true because HBV DNA and HBsAg appear in the blood weeks before symptoms like jaundice. The incubation period of HBV is typically 6 weeks to 6 months, and during this period, the virus is already present in the bloodstream and can be transmitted even before clinical symptoms develop. (D) Age of onset determines the prognosis – Incorrect. This statement is true because the risk of chronicity depends on the age at which infection occurs. Perinatal infections (in newborns) have a 90% chance of progressing to chronic Hepatitis B, whereas infections acquired in adulthood have a less than 5% chance of leading to chronic disease. This highlights the importance of neonatal HBV vaccination to prevent chronic HBV infection.",
      "correct_choice_id": 212096,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10469141700916258/10469141700916258.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10469141700916258/10469141700916258.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96937,
      "choices": [
        {
          "id": 212100,
          "text": "Hepatitis B"
        },
        {
          "id": 212101,
          "text": "Hepatitis A"
        },
        {
          "id": 212102,
          "text": "Hepatitis C"
        },
        {
          "id": 212103,
          "text": "Hepatitis E"
        }
      ],
      "text": "Chronic liver disease is caused by:",
      "unique_key": "Q6835979",
      "question_audio": null,
      "question_video": null,
      "map_id": 34138928,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hepatitis C. Hepatitis C virus (HCV) is a major cause of chronic liver disease, including chronic hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Unlike Hepatitis A and E, which cause acute self-limiting infections, HCV infection becomes chronic in about 75–85% of infected individuals. Over time, chronic HCV infection leads to progressive liver damage, increasing the risk of cirrhosis and liver failure, often requiring liver transplantation. Since Hepatitis C does not have an effective vaccine, early diagnosis and treatment with direct-acting antivirals (DAAs) are essential to prevent long-term complications. Explanation of Incorrect Options: (A) Hepatitis B – Incorrect. Although Hepatitis B virus (HBV) can cause chronic liver disease, it is not the best answer because not all HBV infections become chronic. Around 90% of perinatally acquired infections become chronic, but in adults, less than 5% of infections progress to chronic disease. HBV can lead to chronic hepatitis, cirrhosis, and liver cancer, but vaccination and antiviral treatments can help manage the infection. While Hepatitis B is a major cause of chronic liver disease, Hepatitis C is the more common culprit in chronic cases requiring treatment. (B) Hepatitis A – Incorrect. Hepatitis A virus (HAV) causes only acute hepatitis and does not lead to chronic liver disease. HAV infection is self-limiting, and the body clears the virus completely. While severe cases can cause acute liver failure, they do not progress to chronic hepatitis or cirrhosis. (D) Hepatitis E – Incorrect. Hepatitis E virus (HEV) primarily causes acute hepatitis, similar to HAV. However, in immunocompromised individuals (such as organ transplant recipients or HIV-positive patients), HEV can lead to chronic infection, but this is rare. In most cases, Hepatitis E does not cause chronic liver disease in healthy individuals.",
      "correct_choice_id": 212102,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67039261700916270/67039261700916270.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67039261700916270/67039261700916270.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96938,
      "choices": [
        {
          "id": 212104,
          "text": "Toga virus"
        },
        {
          "id": 212105,
          "text": "Flavivirus"
        },
        {
          "id": 212106,
          "text": "Filovirus"
        },
        {
          "id": 212107,
          "text": "Retrovirus"
        }
      ],
      "text": "Hepatitis C virus is a:",
      "unique_key": "Q3364617",
      "question_audio": null,
      "question_video": null,
      "map_id": 34342635,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Flavivirus. Hepatitis C virus (HCV) belongs to the Flaviviridae family and is classified as a Flavivirus. It is an enveloped, single-stranded, positive-sense RNA virus. Other members of the Flaviviridae family include Dengue virus, Yellow fever virus, West Nile virus, and Zika virus. HCV is unique among flaviviruses because it is primarily bloodborne and causes chronic liver disease rather than acute febrile illnesses like other flaviviruses. HCV infection is a major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. Explanation of Incorrect Options: (A) Toga virus – Incorrect. Togaviruses belong to the Togaviridae family, which includes Rubella virus and Alphaviruses (such as Chikungunya virus). These viruses are also single-stranded RNA viruses, but they do not cause Hepatitis C. The key difference is that Togaviruses primarily cause rash illnesses and arthropathy rather than chronic liver disease. (C) Filovirus – Incorrect. Filoviruses belong to the Filoviridae family, which includes Ebola virus and Marburg virus. These viruses are negative-sense, single-stranded RNA viruses and are known for causing severe hemorrhagic fevers with high mortality rates. Filoviruses have no relation to Hepatitis C, which primarily affects the liver rather than causing systemic hemorrhagic disease. (D) Retrovirus – Incorrect. Retroviruses belong to the Retroviridae family, which includes HIV (Human Immunodeficiency Virus) and HTLV (Human T-cell Leukemia Virus). These viruses are RNA viruses that use reverse transcriptase to integrate into the host genome. Unlike retroviruses, HCV does not integrate into the host genome and does not require reverse transcription for replication.",
      "correct_choice_id": 212105,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39134731700916282/39134731700916282.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39134731700916282/39134731700916282.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96939,
      "choices": [
        {
          "id": 212108,
          "text": "Hepatitis B virus"
        },
        {
          "id": 212109,
          "text": "Hepatitis C virus"
        },
        {
          "id": 212110,
          "text": "Hepatitis E virus"
        },
        {
          "id": 212111,
          "text": "Hepatitis A virus"
        }
      ],
      "text": "A young pregnant woman presents with fulminant hepatic failure. The most likely etiological agent is:",
      "unique_key": "Q1102231",
      "question_audio": null,
      "question_video": null,
      "map_id": 34682581,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hepatitis E virus (HEV). Hepatitis E virus (HEV) infection is the most likely cause of fulminant hepatic failure in pregnant women, particularly in developing countries where HEV is endemic. HEV infection is typically self-limiting in the general population, but during pregnancy, it can lead to severe complications, including fulminant hepatic failure, high maternal mortality (up to 20-30% in the third trimester), and fetal loss. The increased severity in pregnancy is thought to be due to hormonal changes, immune modulation, and a higher viral load. Genotype 1 and 2 HEV strains are particularly associated with severe disease in pregnant women. Explanation of Incorrect Options: (A) Hepatitis B virus (HBV) – Incorrect. Hepatitis B virus (HBV) infection can cause fulminant hepatic failure, but it is relatively rare. Most cases of acute HBV infection resolve without progressing to liver failure. However, if fulminant hepatitis does occur, it is usually due to co-infection with other hepatitis viruses or superinfection with Hepatitis D virus (HDV). Additionally, pregnancy does not significantly worsen the course of acute HBV infection in most cases, unlike HEV. (B) Hepatitis C virus (HCV) – Incorrect. Hepatitis C virus (HCV) does not typically cause acute fulminant hepatitis. HCV infection is usually chronic and progresses slowly over decades, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma rather than acute liver failure. Moreover, pregnancy does not significantly increase the severity of HCV infection. (D) Hepatitis A virus (HAV) – Incorrect. Hepatitis A virus (HAV) can cause acute hepatitis but rarely leads to fulminant hepatic failure. HAV is a self-limiting disease, and even though severe cases can occur in elderly or immunocompromised individuals, pregnant women are not at a significantly higher risk of fulminant hepatitis from HAV.",
      "correct_choice_id": 212110,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23590121700916292/23590121700916292.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23590121700916292/23590121700916292.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96940,
      "choices": [
        {
          "id": 212112,
          "text": "Hepatitis C"
        },
        {
          "id": 212113,
          "text": "Hepatitis B"
        },
        {
          "id": 212114,
          "text": "Hepatitis A"
        },
        {
          "id": 212115,
          "text": "Hepatitis E"
        }
      ],
      "text": "Which of the following acute viral hepatitis infections has the highest risk of progression to chronicity?",
      "unique_key": "Q2389257",
      "question_audio": null,
      "question_video": null,
      "map_id": 34504344,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hepatitis C. Among the acute viral hepatitis infections, Hepatitis C virus (HCV) has the highest risk of progression to chronicity. After acute infection, about 75–85% of individuals fail to clear the virus and develop chronic Hepatitis C, which can lead to chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). Unlike Hepatitis B, which has a lower chronicity rate in adults, most people infected with HCV will develop chronic infection unless treated with direct-acting antivirals (DAAs). There is no effective vaccine for HCV, making prevention and early treatment crucial. Explanation of Incorrect Options: (B) Hepatitis B – Incorrect. While Hepatitis B virus (HBV) can cause chronic infection, the risk depends on the age at which the infection occurs. Perinatal and early childhood infections have a high risk of chronicity (90% in neonates, 30–50% in young children), but in adults, only about 5% of acute HBV infections progress to chronic disease. Since HCV has a much higher chronicity rate than HBV in adults, HCV is the correct answer in this context. (C) Hepatitis A – Incorrect. Hepatitis A virus (HAV) does not cause chronic infection. It leads to acute, self-limiting hepatitis, and the immune system clears the virus completely. Once infected, lifelong immunity develops, preventing reinfection. Since HAV never progresses to chronicity, it is not the correct answer. (D) Hepatitis E – Incorrect. Hepatitis E virus (HEV) is typically an acute and self-limiting infection, similar to HAV. However, in immunocompromised individuals (e.g., transplant recipients, HIV-positive patients), HEV can lead to chronic infection, particularly with genotype 3 and 4 HEV strains. Despite this, the overall risk of chronicity is far lower than HCV. Additionally, pregnant women are at high risk for severe acute HEV infection, but not chronicity.",
      "correct_choice_id": 212112,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77646101700916303/77646101700916303.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77646101700916303/77646101700916303.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96941,
      "choices": [
        {
          "id": 212116,
          "text": "blood route"
        },
        {
          "id": 212117,
          "text": "Inhalation"
        },
        {
          "id": 212118,
          "text": "Feco-oral route"
        },
        {
          "id": 212119,
          "text": "All"
        }
      ],
      "text": "Hepatitis A is transmitted by:",
      "unique_key": "Q7088060",
      "question_audio": null,
      "question_video": null,
      "map_id": 34314613,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Feco-oral route. Hepatitis A virus (HAV) is primarily transmitted through the fecal-oral route, meaning that infection occurs when a person consumes food or water contaminated with fecal matter containing HAV. This mode of transmission is common in areas with poor sanitation and hygiene. Outbreaks of Hepatitis A often occur due to contaminated water, unwashed fruits and vegetables, raw shellfish, or close person-to-person contact in crowded or unsanitary conditions. HAV is highly infectious but does not cause chronic liver disease and is usually self-limiting. Vaccination is an effective preventive measure. Explanation of Incorrect Options: (A) Blood route – Incorrect. Unlike Hepatitis B and C, Hepatitis A is not transmitted through blood or blood products. Viremia (the presence of HAV in blood) occurs briefly during infection, but bloodborne transmission is extremely rare. (B) Inhalation – Incorrect. HAV is not transmitted through respiratory droplets or airborne inhalation. Unlike viruses that spread through the respiratory route (such as influenza or COVID-19), HAV requires ingestion of contaminated food or water. (D) All – Incorrect. Since HAV is only transmitted through the fecal-oral route, not via blood or inhalation, option D is incorrect.",
      "correct_choice_id": 212118,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76778631700916317/76778631700916317.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76778631700916317/76778631700916317.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96942,
      "choices": [
        {
          "id": 212120,
          "text": "Sex"
        },
        {
          "id": 212121,
          "text": "Feco-oral"
        },
        {
          "id": 212122,
          "text": "Blood transfusion"
        },
        {
          "id": 212123,
          "text": "IV injections"
        }
      ],
      "text": "Most common route of spread of hepatitis E is:",
      "unique_key": "Q8848841",
      "question_audio": null,
      "question_video": null,
      "map_id": 34446454,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) (B) Feco-oral. Hepatitis E virus (HEV) is primarily transmitted through the fecal-oral route, meaning infection occurs when a person ingests food or water contaminated with fecal matter containing HEV. Contaminated drinking water is the most common source of large HEV outbreaks, especially in developing countries with poor sanitation. HEV is similar to Hepatitis A in its transmission, but it is particularly dangerous for pregnant women, where it can cause fulminant hepatic failure and high maternal mortality. Explanation of Incorrect Options: (A) Sex – Incorrect. Sexual transmission of Hepatitis E is extremely rare. Unlike Hepatitis B and C, which are commonly spread through sexual contact, HEV does not efficiently transmit via sexual activity. (C) Blood transfusion – Incorrect. Bloodborne transmission of HEV is possible but uncommon. HEV RNA has been detected in blood donors, and there have been rare cases of HEV transmission through blood transfusion, particularly with genotype 3 HEV in immunocompromised patients. However, this is not the primary mode of transmission. (D) IV injections – Incorrect. Intravenous (IV) drug use is a significant route for Hepatitis B and C transmission but not for Hepatitis E. HEV does not efficiently spread through contaminated needles or IV drug use.",
      "correct_choice_id": 212121,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75077611700916330/75077611700916330.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75077611700916330/75077611700916330.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96943,
      "choices": [
        {
          "id": 212124,
          "text": "HBsAg"
        },
        {
          "id": 212125,
          "text": "HBeAg"
        },
        {
          "id": 212126,
          "text": "IgM anti-HBc"
        },
        {
          "id": 212127,
          "text": "HBcAg"
        }
      ],
      "text": "Serological markers of infectivity of hepatitis B:",
      "unique_key": "Q3017182",
      "question_audio": null,
      "question_video": null,
      "map_id": 34401813,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) HBeAg. Hepatitis B e-antigen (HBeAg) is the most important serological marker of active viral replication and infectivity in Hepatitis B virus (HBV) infection. The presence of HBeAg in the blood indicates that the virus is actively replicating, and the patient has a high viral load, making them highly infectious. HBeAg is produced by the core region of HBV and is detected in the early phase of infection. Its persistence suggests chronic active HBV infection and increased risk of disease progression (e.g., chronic hepatitis, cirrhosis, and hepatocellular carcinoma). The disappearance of HBeAg and the appearance of anti-HBe antibodies indicate a reduction in viral replication and infectivity. Explanation of Incorrect Options: (A) HBsAg (Hepatitis B surface antigen) – Incorrect. HBsAg is a marker of HBV infection but not necessarily infectivity. It appears early in the course of infection and is used as the primary screening marker for HBV. However, its presence does not directly indicate active viral replication, as patients can be HBsAg-positive but have low or undetectable viral load if HBeAg is absent and anti-HBe is present. (C) IgM anti-HBc (IgM antibody to hepatitis B core antigen) – Incorrect. IgM anti-HBc is a marker of recent HBV infection. It is used to detect acute or recent HBV infection and is present during the window period when HBsAg disappears but before anti-HBs antibodies appear. However, it does not indicate ongoing viral replication or infectivity. (D) HBcAg (Hepatitis B core antigen) – Incorrect. HBcAg is found only inside infected hepatocytes and is not detectable in the blood. It plays a role in viral replication but is not used as a serological marker for infectivity because it is not secreted into circulation.",
      "correct_choice_id": 212125,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20289281700916343/20289281700916343.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20289281700916343/20289281700916343.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96944,
      "choices": [
        {
          "id": 212128,
          "text": "Hepatitis A"
        },
        {
          "id": 212129,
          "text": "Hepatitis B"
        },
        {
          "id": 212130,
          "text": "Hepatitis C"
        },
        {
          "id": 212131,
          "text": "Hepatitis D"
        }
      ],
      "text": "Which is DNA virus?",
      "unique_key": "Q9924240",
      "question_audio": null,
      "question_video": null,
      "map_id": 34432770,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hepatitis B. Hepatitis B virus (HBV) is the only DNA virus among the hepatitis viruses. It belongs to the Hepadnaviridae family and has a partially double-stranded, circular DNA genome. Unlike other DNA viruses, HBV replicates using reverse transcription, a characteristic usually seen in retroviruses. HBV infection can lead to acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). The presence of HBsAg (Hepatitis B surface antigen) in the blood is a key diagnostic marker for active HBV infection. Explanation of Incorrect Options: (A) Hepatitis A – Incorrect. Hepatitis A virus (HAV) is an RNA virus belonging to the Picornaviridae family. It has a single-stranded, positive-sense RNA genome. HAV is transmitted through the fecal-oral route and does not cause chronic infection. It primarily leads to acute, self-limiting hepatitis with lifelong immunity after recovery. (C) Hepatitis C – Incorrect. Hepatitis C virus (HCV) is an RNA virus from the Flaviviridae family. It has a single-stranded, positive-sense RNA genome. HCV is bloodborne and has a high risk of progressing to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Unlike HBV, HCV does not integrate into the host genome and does not use reverse transcription. (D) Hepatitis D – Incorrect. Hepatitis D virus (HDV) is an RNA virus with a single-stranded, circular RNA genome. It is classified as a Deltavirus and is unique because it requires Hepatitis B virus (HBV) for replication. HDV is a satellite virus that depends on HBV for the production of its envelope protein (HBsAg). It can cause severe liver disease, particularly in HBV-HDV co-infections or superinfections.",
      "correct_choice_id": 212129,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64388191700916358/64388191700916358.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64388191700916358/64388191700916358.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96945,
      "choices": [
        {
          "id": 212132,
          "text": "HBV"
        },
        {
          "id": 212133,
          "text": "HCV"
        },
        {
          "id": 212134,
          "text": "HDV"
        },
        {
          "id": 212135,
          "text": "HEV"
        }
      ],
      "text": "Which of the following does not go into chronic hepatitis stage:",
      "unique_key": "Q1674265",
      "question_audio": null,
      "question_video": null,
      "map_id": 34465635,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hepatitis E virus (HEV). Hepatitis E virus (HEV) does not usually progress to chronic hepatitis in immunocompetent individuals. HEV infection is generally self-limiting, causing acute viral hepatitis that resolves without long-term complications. It is primarily transmitted via the fecal-oral route through contaminated food and water. However, in immunocompromised individuals (e.g., organ transplant recipients, HIV-positive patients), particularly those infected with HEV genotype 3 or 4, there is a rare possibility of chronic HEV infection. Despite this, HEV is not considered a major cause of chronic hepatitis compared to HBV, HCV, and HDV. Explanation of Incorrect Options: (A) HBV (Hepatitis B virus) – Incorrect. Hepatitis B virus (HBV) is a well-known cause of chronic hepatitis. The risk of developing chronic infection depends on the age at which the infection occurs: Neonates: ~90% progress to chronic infection Children (1–5 years): ~30–50% progress to chronic infection Adults: ~5% progress to chronic infection Chronic HBV infection can lead to cirrhosis, liver failure, and hepatocellular carcinoma (HCC). (B) HCV (Hepatitis C virus) – Incorrect. Hepatitis C virus (HCV) has the highest risk of chronicity among all hepatitis viruses. Around 75–85% of acute HCV infections progress to chronic hepatitis, which can eventually cause liver fibrosis, cirrhosis, and hepatocellular carcinoma. Unlike HBV, which integrates into the host genome, HCV persists as an RNA virus in liver cells, making it difficult for the immune system to eliminate. (C) HDV (Hepatitis D virus) – Incorrect. Hepatitis D virus (HDV) is an RNA virus that depends on HBV for replication. HDV infection occurs only in individuals already infected with HBV (co-infection or superinfection). Superinfection with HDV in an HBV carrier significantly increases the risk of chronic hepatitis and liver failure. HDV infection is associated with the most severe form of viral hepatitis, often leading to rapid progression to cirrhosis and liver cancer.",
      "correct_choice_id": 212135,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63400271700916370/63400271700916370.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63400271700916370/63400271700916370.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96946,
      "choices": [
        {
          "id": 212136,
          "text": "Adw"
        },
        {
          "id": 212137,
          "text": "Ayw"
        },
        {
          "id": 212138,
          "text": "Adr"
        },
        {
          "id": 212139,
          "text": "Ayr"
        }
      ],
      "text": "HBV present in India is:",
      "unique_key": "Q1618794",
      "question_audio": null,
      "question_video": null,
      "map_id": 34622379,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Ayw. In India, the predominant subtype of Hepatitis B virus (HBV) is Ayw. HBV is classified into four major serotypes (adw, ayw, adr, and ayr) based on variations in the HBsAg (Hepatitis B surface antigen). The Ayw subtype is the most prevalent in South Asia, including India, and is commonly associated with genotypes D and A, which are widespread in this region. Genotype D is particularly linked with chronic HBV infection and a higher risk of liver disease progression. The distribution of HBV subtypes varies geographically, influencing disease outcomes and vaccine responses. Explanation of Incorrect Options: (A) Adw – Incorrect. The Adw subtype is primarily found in Europe, North America, and parts of Africa. It is associated with HBV genotypes A and B, which are more common in Western countries but not the dominant strain in India. (C) Adr – Incorrect. The Adr subtype is mostly found in East Asia, including China, Japan, and Southeast Asia. It is linked to HBV genotype C, which is associated with a more severe disease course and a higher risk of hepatocellular carcinoma (HCC). However, this subtype is not common in India. (D) Ayr – Incorrect. The Ayr subtype is extremely rare and is not a major circulating strain in India. Its distribution is not well characterized, and it is not considered a significant contributor to HBV infection in the Indian population.",
      "correct_choice_id": 212137,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29225851700916385/29225851700916385.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29225851700916385/29225851700916385.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96947,
      "choices": [
        {
          "id": 212140,
          "text": "Transmitted by feco-oral route"
        },
        {
          "id": 212141,
          "text": "Is a DNA virus"
        },
        {
          "id": 212142,
          "text": "Has independent existence"
        },
        {
          "id": 212143,
          "text": "Resembles some plant viruses"
        }
      ],
      "text": "Hepatitis D virus:",
      "unique_key": "Q2520032",
      "question_audio": null,
      "question_video": null,
      "map_id": 34089578,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Resembles some plant viruses. Hepatitis D virus (HDV) is unique among human viruses because it shares similarities with viroids and some plant viruses. Like plant viroids, HDV has a small, single-stranded, circular RNA genome and does not encode its own envelope proteins. It depends entirely on Hepatitis B virus (HBV) for replication and assembly, using the HBsAg (Hepatitis B surface antigen) to form its viral envelope. Due to these characteristics, HDV is often referred to as a defective or satellite virus. Its mode of replication and structure resemble certain plant pathogens, making it distinct from other human hepatitis viruses. Explanation of Incorrect Options: (A) Transmitted by fecal-oral route – Incorrect. HDV is not transmitted via the fecal-oral route. Unlike Hepatitis A and E, which spread through contaminated food and water, HDV is transmitted through blood and body fluids, similar to Hepatitis B. Routes of transmission include intravenous drug use, sexual contact, and vertical transmission from mother to child. (B) Is a DNA virus – Incorrect. HDV is an RNA virus, not a DNA virus. It has a single-stranded, circular RNA genome, unlike HBV, which is a DNA virus. HDV's RNA genome is unique in that it forms a rod-like secondary structure, making it similar to plant viroids. (C) Has independent existence – Incorrect. HDV cannot exist independently. It is a satellite virus that requires Hepatitis B virus (HBV) for replication and transmission. Without HBV, HDV cannot produce infectious particles, as it lacks genes to encode its own envelope proteins. HDV infection occurs either as a co-infection (simultaneous infection with HBV) or as a superinfection (HDV infection in an already HBV-infected individual), leading to severe liver disease.",
      "correct_choice_id": 212143,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40886211700916398/40886211700916398.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40886211700916398/40886211700916398.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96948,
      "choices": [
        {
          "id": 212144,
          "text": "Hepatitis D Defective virus"
        },
        {
          "id": 212145,
          "text": "Hepatitis C Parenteral transmission"
        },
        {
          "id": 212146,
          "text": "Hepatitis B RNA virus"
        },
        {
          "id": 212147,
          "text": "Hepatitis E Feco-oral transmission"
        }
      ],
      "text": "Which of the following is not matched correctly:",
      "unique_key": "Q5460134",
      "question_audio": null,
      "question_video": null,
      "map_id": 34506782,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hepatitis B – RNA virus, which is incorrect because Hepatitis B virus (HBV) is a DNA virus, not an RNA virus. HBV belongs to the Hepadnaviridae family and has a partially double-stranded circular DNA genome. Unlike other DNA viruses, HBV replicates through reverse transcription, a process commonly seen in retroviruses. It is the only DNA virus among the hepatitis viruses. HBV infection can lead to acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC), with transmission occurring via blood, sexual contact, and perinatal routes. Explanation of Incorrect Options: (A) Hepatitis D – Defective virus – Correct. Hepatitis D virus (HDV) is a defective (satellite) virus that requires Hepatitis B virus (HBV) for its replication. HDV lacks its own envelope proteins and depends on HBV's HBsAg for assembly and transmission. It has a single-stranded, circular RNA genome and is associated with more severe liver disease, including rapid progression to cirrhosis and liver failure. (B) Hepatitis C – Parenteral transmission – Correct. Hepatitis C virus (HCV) is primarily transmitted through parenteral routes, meaning it spreads through blood and body fluids. Common modes of transmission include intravenous drug use, blood transfusions (before screening), needle-stick injuries, and unprotected sex with an infected person. Unlike HBV, perinatal and sexual transmission of HCV is less efficient, but still possible. (D) Hepatitis E – Feco-oral transmission – Correct. Hepatitis E virus (HEV) is transmitted primarily through the fecal-oral route, similar to Hepatitis A. It is associated with contaminated water and food, particularly in developing countries. HEV infection is usually self-limiting, but in pregnant women, it can cause fulminant hepatitis with high mortality rates.",
      "correct_choice_id": 212146,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50133841700916411/50133841700916411.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50133841700916411/50133841700916411.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96949,
      "choices": [
        {
          "id": 212148,
          "text": "HBsAg"
        },
        {
          "id": 212149,
          "text": "HBc"
        },
        {
          "id": 212150,
          "text": "HBe"
        },
        {
          "id": 212151,
          "text": "All of the above"
        }
      ],
      "text": "Hepatitis B virus vaccine contain:",
      "unique_key": "Q1659701",
      "question_audio": null,
      "question_video": null,
      "map_id": 34287959,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) HBsAg. The Hepatitis B vaccine contains Hepatitis B surface antigen (HBsAg), which is used to stimulate an immune response and provide protection against Hepatitis B virus (HBV) infection. The vaccine is a recombinant subunit vaccine, meaning it is produced using genetic engineering techniques. HBsAg is synthesized in yeast or mammalian cells and does not contain any live virus, making it safe and highly effective. The immune system recognizes HBsAg as a foreign antigen and produces protective antibodies (anti-HBs), which neutralize the virus if exposure occurs in the future. The vaccine is given as a series of three or four doses and provides long-term immunity. Explanation of Incorrect Options: (B) HBc (Hepatitis B core antigen) – Incorrect. HBcAg (Hepatitis B core antigen) is not included in the vaccine. It is found within the viral nucleocapsid and does not appear in the bloodstream. Antibodies against HBcAg (anti-HBc) indicate past or current HBV infection but do not provide protective immunity. (C) HBe (Hepatitis B e antigen) – Incorrect. HBeAg is a secretory protein associated with active HBV replication and high infectivity. It is not a structural part of the virus and does not play a role in vaccine-induced immunity. HBeAg is mainly used as a marker for disease activity and infectivity in HBV-infected individuals. (D) All of the above – Incorrect. The Hepatitis B vaccine only contains HBsAg, not HBcAg or HBeAg. The goal of vaccination is to generate protective anti-HBs antibodies, which prevent HBV infection and its complications.",
      "correct_choice_id": 212148,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77531641700916423/77531641700916423.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77531641700916423/77531641700916423.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96950,
      "choices": [
        {
          "id": 212152,
          "text": "Hep A"
        },
        {
          "id": 212153,
          "text": "Hep D"
        },
        {
          "id": 212154,
          "text": "Hep B"
        },
        {
          "id": 212155,
          "text": "Hep C"
        }
      ],
      "text": "Dependent hepatitis virus is:",
      "unique_key": "Q1884799",
      "question_audio": null,
      "question_video": null,
      "map_id": 34317572,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hepatitis D virus (HDV). Hepatitis D virus is a defective or dependent virus that requires Hepatitis B virus (HBV) for replication and transmission. HDV lacks the genetic machinery to produce its own envelope proteins and instead uses the Hepatitis B surface antigen (HBsAg) from HBV to form its viral envelope. Because of this dependence, HDV infection can only occur in individuals who are already infected with HBV (co-infection) or those who acquire HDV later in an existing HBV infection (superinfection). HDV superinfection leads to more severe liver disease, including rapid progression to cirrhosis and liver failure. Explanation of Incorrect Options: (A) Hepatitis A virus (HAV) – Incorrect. HAV is an independent virus and does not require another virus for replication. It is a single-stranded RNA virus that spreads via the fecal-oral route and causes acute hepatitis. Unlike HDV, HAV does not lead to chronic infection or liver failure in immunocompetent individuals. (C) Hepatitis B virus (HBV) – Incorrect. HBV is a complete, independent DNA virus that does not depend on any other virus for its replication. In contrast, HDV depends entirely on HBV for transmission and replication. HBV infection can occur alone, whereas HDV cannot. (D) Hepatitis C virus (HCV) – Incorrect. HCV is an independent RNA virus that belongs to the Flaviviridae family. It spreads mainly through blood and body fluids, causing both acute and chronic hepatitis. HCV does not require another virus to replicate, unlike HDV.",
      "correct_choice_id": 212153,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59842871700916436/59842871700916436.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59842871700916436/59842871700916436.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96951,
      "choices": [
        {
          "id": 212156,
          "text": "Saliva"
        },
        {
          "id": 212157,
          "text": "Semen"
        },
        {
          "id": 212158,
          "text": "Stool"
        },
        {
          "id": 212159,
          "text": "None"
        }
      ],
      "text": "Hep B is not secreted in:",
      "unique_key": "Q9283633",
      "question_audio": null,
      "question_video": null,
      "map_id": 34404450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Stool. Hepatitis B virus (HBV) is not secreted in stool because the virus primarily spreads through blood and body fluids, not the fecal-oral route. HBV is present in high concentrations in blood and moderate concentrations in other bodily fluids such as semen, vaginal secretions, and saliva. However, it is not excreted in stool, which is why HBV is not transmitted through contaminated food or water, unlike Hepatitis A and E. The primary modes of HBV transmission include blood transfusion, sexual contact, perinatal transmission, and sharing contaminated needles. Explanation of Incorrect Options: (A) Saliva – Incorrect. HBV can be found in saliva, though in lower concentrations than in blood or semen. While HBV is present in saliva, casual contact like kissing or sharing utensils is not a significant mode of transmission unless there are open wounds or bleeding gums. (B) Semen – Incorrect. HBV is present in semen, making sexual transmission one of the primary routes of infection. Unprotected sexual contact, particularly in high-risk individuals, is a major way HBV spreads. This is why HBV is classified as a sexually transmitted infection (STI). (D) None – Incorrect. This option implies that HBV is secreted in all listed fluids, which is incorrect because HBV is not secreted in stool.",
      "correct_choice_id": 212158,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/5437721700916447/5437721700916447.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/5437721700916447/5437721700916447.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96952,
      "choices": [
        {
          "id": 212160,
          "text": "Highest rate of chronicity among all hepatitis viruses"
        },
        {
          "id": 212161,
          "text": "Can be cultured"
        },
        {
          "id": 212162,
          "text": "Diagnosed by detection of HCV RNA"
        },
        {
          "id": 212163,
          "text": "Transmitted through transfusion of infected blood"
        }
      ],
      "text": "True about HCV include all except:",
      "unique_key": "Q1019745",
      "question_audio": null,
      "question_video": null,
      "map_id": 34426810,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Can be cultured, which is incorrect because Hepatitis C virus (HCV) cannot be reliably cultured in standard laboratory conditions. Unlike some other viruses, HCV does not grow well in conventional cell culture systems, making research and vaccine development challenging. Although there have been advancements in developing in vitro culture models using hepatocyte-like cells and advanced tissue culture systems, routine culturing of HCV in clinical laboratories is still not feasible. Explanation of Incorrect Options: (A) Highest rate of chronicity among all hepatitis viruses – Correct. HCV has the highest rate of chronicity, with approximately 75-85% of infected individuals developing chronic hepatitis. This is much higher than Hepatitis B, which progresses to chronic infection in about 5-10% of adult cases (though the rate is higher in neonates and infants). Chronic HCV infection can lead to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) if left untreated. (C) Diagnosed by detection of HCV RNA – Correct. HCV RNA detection using polymerase chain reaction (PCR) is the most sensitive and specific test for diagnosing active HCV infection. While anti-HCV antibodies indicate past or present infection, the presence of HCV RNA confirms an ongoing infection and is used to monitor treatment response. (D) Transmitted through transfusion of infected blood – Correct. HCV is primarily transmitted through blood-to-blood contact, and infected blood transfusion was a major route before routine screening began. Other transmission routes include intravenous drug use (IVDU), unsafe medical procedures, needle-stick injuries, and, less commonly, sexual and perinatal transmission.",
      "correct_choice_id": 212161,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54014571700916459/54014571700916459.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54014571700916459/54014571700916459.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96953,
      "choices": [
        {
          "id": 212164,
          "text": "Hepatitis B"
        },
        {
          "id": 212165,
          "text": "Hepatitis C"
        },
        {
          "id": 212166,
          "text": "Hepatitis D"
        },
        {
          "id": 212167,
          "text": "Hepatitis E"
        }
      ],
      "text": "All of the following hepatitis virus can be transmitted through blood except",
      "unique_key": "Q3931854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34243135,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hepatitis E. Hepatitis E virus (HEV) is primarily transmitted via the fecal-oral route, usually through contaminated water or food, rather than through blood. HEV infection is more common in developing countries with poor sanitation. While rare cases of HEV transmission through blood transfusion have been reported, it is not a significant route of transmission. The primary concern with HEV is its potential to cause fulminant hepatitis, especially in pregnant women, where mortality rates can be high. Explanation of Incorrect Options: (A) Hepatitis B – Incorrect. Hepatitis B virus (HBV) is efficiently transmitted through blood and body fluids, including infected blood transfusions, needle-sharing, sexual contact, and perinatal transmission. HBV is a major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). (B) Hepatitis C – Incorrect. Hepatitis C virus (HCV) is a bloodborne virus, with blood transfusion, intravenous drug use (IVDU), and unsafe medical procedures being the most common transmission routes. HCV is a leading cause of chronic liver disease and cirrhosis, and unlike HBV, there is no preventive vaccine available. (C) Hepatitis D – Incorrect. Hepatitis D virus (HDV) is also transmitted through blood, similar to HBV. However, HDV is a defective virus that requires co-infection with HBV for replication. HDV infection worsens HBV-related liver disease, leading to more severe complications such as rapid progression to cirrhosis and liver failure.",
      "correct_choice_id": 212167,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63207521700916475/63207521700916475.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63207521700916475/63207521700916475.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96954,
      "choices": [
        {
          "id": 212168,
          "text": "Both can infect simultaneously"
        },
        {
          "id": 212169,
          "text": "HDV can cause more serious infection due to super infection"
        },
        {
          "id": 212170,
          "text": "HDV cannot infect in absence of HBV"
        },
        {
          "id": 212171,
          "text": "HDV is a DNA virus"
        }
      ],
      "text": "Regarding HBV and HDV,false is:",
      "unique_key": "Q5493625",
      "question_audio": null,
      "question_video": null,
      "map_id": 34323963,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) HDV is a DNA virus, which is false because Hepatitis D virus (HDV) is an RNA virus, not a DNA virus. HDV is a defective single-stranded RNA virus that requires the presence of Hepatitis B virus (HBV) for replication and transmission. It does not have its own envelope proteins and relies on HBV surface antigen (HBsAg) to form infectious viral particles. Because it is an RNA virus, it does not integrate into the host genome like HBV (which is a DNA virus). Explanation of Incorrect Options: (A) Both can infect simultaneously – Correct. HBV and HDV can co-infect a person at the same time (simultaneous or co-infection). This occurs when a person is exposed to both viruses at once, often through blood transfusions or intravenous drug use. In co-infections, the immune response is stronger, and the likelihood of clearing both viruses is higher, though acute hepatitis may be more severe. (B) HDV can cause more serious infection due to superinfection – Correct. Superinfection occurs when an individual with chronic HBV later acquires HDV, leading to a more severe and rapidly progressive liver disease. HDV superinfection is associated with a higher risk of fulminant hepatitis, cirrhosis, and liver failure compared to HBV infection alone. Unlike co-infection, superinfection usually leads to chronic HDV infection with worse outcomes. (C) HDV cannot infect in the absence of HBV – Correct. HDV is entirely dependent on HBV for its life cycle. It requires HBsAg for viral assembly and transmission, meaning that HDV cannot infect or cause disease without the presence of HBV.",
      "correct_choice_id": 212171,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51635751700916487/51635751700916487.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51635751700916487/51635751700916487.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96955,
      "choices": [
        {
          "id": 212172,
          "text": "SS RNA virus"
        },
        {
          "id": 212173,
          "text": "SS DNA virus"
        },
        {
          "id": 212174,
          "text": "DS RNA virus"
        },
        {
          "id": 212175,
          "text": "IDS DNA virus"
        }
      ],
      "text": "HDV is",
      "unique_key": "Q3736314",
      "question_audio": null,
      "question_video": null,
      "map_id": 34766778,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) SS RNA virus. Hepatitis D virus (HDV) is a single-stranded RNA (SS RNA) virus. It is a defective virus that requires the Hepatitis B virus (HBV) for replication and transmission. HDV has a small, circular, negative-sense RNA genome, making it unique among human pathogens. It is structurally similar to plant viroids and depends on HBV surface antigen (HBsAg) to form infectious viral particles. HDV infection is associated with severe liver disease, including fulminant hepatitis and rapid progression to cirrhosis. Explanation of Incorrect Options: (B) SS DNA virus – Incorrect. HDV is not a DNA virus but an RNA virus. Single-stranded DNA (SS DNA) viruses exist, but HDV does not belong to this category. Unlike HBV (which is a DNA virus), HDV does not integrate into the host genome. (C) DS RNA virus – Incorrect. HDV has a single-stranded RNA genome, not a double-stranded (DS) RNA genome. DS RNA viruses, such as Rotavirus, belong to the Reoviridae family, while HDV is unique and does not fit into this classification. (D) DS DNA virus – Incorrect. HDV is not a DNA virus at all. Double-stranded (DS) DNA viruses, such as Hepatitis B virus (HBV), Herpesviruses, and Poxviruses, use DNA as their genetic material, whereas HDV is solely an RNA virus.",
      "correct_choice_id": 212172,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73343551700916498/73343551700916498.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73343551700916498/73343551700916498.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96956,
      "choices": [
        {
          "id": 212176,
          "text": "IgM anti HBe"
        },
        {
          "id": 212177,
          "text": "IgM anti HBc"
        },
        {
          "id": 212178,
          "text": "IgG anti HBe"
        },
        {
          "id": 212179,
          "text": "IgM anti HBs"
        }
      ],
      "text": "First antibody to appear in hepatitis:",
      "unique_key": "Q8687588",
      "question_audio": null,
      "question_video": null,
      "map_id": 34407886,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) IgM anti-HBc. IgM anti-HBc (Immunoglobulin M against Hepatitis B core antigen) is the first antibody to appear in acute Hepatitis B infection. It emerges shortly after the onset of symptoms and persists for several months, making it a key marker for recent HBV infection. IgM anti-HBc is especially useful in diagnosing acute and recent HBV infections, even during the \"window period\"—a phase when HBsAg has disappeared but anti-HBs has not yet appeared. Explanation of Incorrect Options: (A) IgM anti-HBe – Incorrect. IgM anti-HBe (antibody to Hepatitis B e antigen) appears later in the course of infection. While it is associated with decreasing viral replication and lower infectivity, it does not appear as early as IgM anti-HBc. (C) IgG anti-HBe – Incorrect. IgG anti-HBe appears even later than IgM anti-HBe and is a marker of past infection or recovery. It signifies a transition towards viral clearance and lower infectivity. (D) IgM anti-HBs – Incorrect. Anti-HBs (antibody to Hepatitis B surface antigen) appears only after recovery or vaccination. It is not the first antibody to appear in an active infection. IgM anti-HBs does not exist—anti-HBs is primarily of the IgG class and is responsible for long-term immunity.",
      "correct_choice_id": 212177,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75305331700916510/75305331700916510.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75305331700916510/75305331700916510.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96957,
      "choices": [
        {
          "id": 212180,
          "text": "occurs with Hepatitis B"
        },
        {
          "id": 212181,
          "text": "Is single stranded DNA virus"
        },
        {
          "id": 212182,
          "text": "Occurs along with HIV"
        },
        {
          "id": 212183,
          "text": "Increases mortality in pregnancy"
        }
      ],
      "text": "Regarding Hepatitis E, it is true that:",
      "unique_key": "Q1920998",
      "question_audio": null,
      "question_video": null,
      "map_id": 34947099,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Increases mortality in pregnancy Explanation of the Correct Answer: Hepatitis E virus (HEV) is a single-stranded, positive-sense RNA virus belonging to the Hepeviridae family. It is a self-limiting viral hepatitis, primarily transmitted via the fecal-oral route, often through contaminated water. Severe in Pregnancy: Pregnant women, particularly in the third trimester, are at high risk for developing fulminant hepatic failure due to HEV infection. The mortality rate can reach 20-30% in pregnant women, significantly higher than in the general population. The exact cause is not fully understood, but it is believed to involve immune modulation during pregnancy, hormonal changes, and liver dysfunction. Pre-term labor, intrauterine fetal death, and vertical transmission to the baby can also occur. Epidemiology: HEV is endemic in developing countries, especially in South Asia, Africa, and parts of the Middle East. Outbreaks are common in areas with poor sanitation and unsafe drinking water. Prevention & Management: Supportive treatment is the mainstay, as no specific antiviral therapy is widely available. Vaccination (Hecolin®?) is available in China but not globally. Pregnant women should avoid travel to endemic areas and consume only safe drinking water. Explanation of Incorrect Options: (A) Occurs with Hepatitis B – Incorrect Hepatitis E and Hepatitis B do not co-infect as Hepatitis B is a DNA virus (Hepadnavirus family), while HEV is an RNA virus. Hepatitis D, not Hepatitis E, is associated with Hepatitis B co-infection, as HDV requires the Hepatitis B surface antigen (HBsAg) for replication. HEV typically occurs independently, with outbreaks linked to contaminated water sources rather than parenteral transmission (like Hepatitis B and C). (B) Is a Single-Stranded DNA Virus – Incorrect HEV is a single-stranded, positive-sense RNA virus, not a DNA virus. The only hepatitis virus that is a DNA virus is Hepatitis B (HBV), which belongs to the Hepadnaviridae family. (C) Occurs Along with HIV – Incorrect While HIV-positive individuals can contract Hepatitis E, it is not a defining feature of HEV. HEV is not linked to HIV co-infection the way Hepatitis B (HBV) or Hepatitis C (HCV) is. However, in HIV-positive patients, HEV may cause chronic infection rather than its usual acute course.",
      "correct_choice_id": 212183,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39503371700905399/39503371700905399.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39503371700905399/39503371700905399.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96958,
      "choices": [
        {
          "id": 212184,
          "text": "Hepatitis B"
        },
        {
          "id": 212185,
          "text": "Sabin"
        },
        {
          "id": 212186,
          "text": "17D (yellow fever)"
        },
        {
          "id": 212187,
          "text": "BCG"
        }
      ],
      "text": "Live vaccine except",
      "unique_key": "Q6796843",
      "question_audio": null,
      "question_video": null,
      "map_id": 34569479,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hepatitis B Explanation of the Correct Answer: Hepatitis B vaccine is not a live vaccine; it is a recombinant subunit vaccine that contains Hepatitis B surface antigen (HBsAg) produced using recombinant DNA technology in yeast cells (Saccharomyces cerevisiae). The Hepatitis B vaccine induces an immune response by stimulating the production of anti-HBs antibodies, which provide protection against HBV infection. It is safe for immunocompromised individuals and pregnant women because it does not contain live virus. The vaccine is given as intramuscular (IM) injections in a 3-dose schedule (0, 1, and 6 months). Explanation of Incorrect Options: (B) Sabin (Oral Polio Vaccine - OPV) – Incorrect Sabin vaccine (OPV) is a live-attenuated oral vaccine containing weakened poliovirus strains. Provides strong mucosal (IgA) immunity, preventing both disease and transmission. However, rare cases of vaccine-derived poliovirus (VDPV) and vaccine-associated paralytic polio (VAPP) can occur. (C) 17D (Yellow Fever Vaccine) – Incorrect The 17D strain yellow fever vaccine is a live-attenuated viral vaccine. Provides lifelong immunity after a single dose. Recommended for travelers to yellow fever-endemic areas (Africa, South America). Contraindicated in immunocompromised individuals, infants <6 months, and pregnant women due to the live nature of the virus. (D) BCG (Bacillus Calmette-Guérin) – Incorrect BCG is a live-attenuated vaccine derived from Mycobacterium bovis. It is primarily used for tuberculosis (TB) prevention, especially in countries with high TB prevalence. Also provides some protection against leprosy and bladder cancer (used in intravesical therapy for superficial bladder cancer). Contraindicated in immunocompromised individuals (e.g., HIV-positive patients) due to the risk of disseminated infection.",
      "correct_choice_id": 212184,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19055811700905470/19055811700905470.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19055811700905470/19055811700905470.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96959,
      "choices": [
        {
          "id": 212188,
          "text": "HepatitisAvirus"
        },
        {
          "id": 212189,
          "text": "Hepatitis Bvirus"
        },
        {
          "id": 212190,
          "text": "Hepatitis C virus"
        },
        {
          "id": 212191,
          "text": "Hepatitis D virus"
        }
      ],
      "text": "All the following hepatitis viruses are RNAvirus except",
      "unique_key": "Q3206125",
      "question_audio": null,
      "question_video": null,
      "map_id": 34374352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hepatitis B Virus (HBV) Explanation of the Correct Answer: Hepatitis B virus (HBV) is the only DNA virus among the hepatitis viruses. It belongs to the Hepadnaviridae family and has a partially double-stranded circular DNA genome. HBV replicates using a reverse transcriptase enzyme, similar to retroviruses, though it is not classified as one. The virus primarily infects hepatocytes, leading to acute or chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). HBV transmission occurs through blood, sexual contact, and perinatal transmission (mother to child). The HBsAg (Hepatitis B surface antigen) is used for diagnosis, and the Hepatitis B vaccine (recombinant subunit vaccine) provides effective protection. Explanation of Incorrect Options: (A) Hepatitis A Virus (HAV) – Incorrect HAV is an RNA virus belonging to the Picornaviridae family. It has a single-stranded, positive-sense RNA genome. Causes acute hepatitis but does not lead to chronic infection. Spread via the fecal-oral route, often through contaminated food or water. Preventable by the Hepatitis A vaccine (inactivated virus vaccine). (C) Hepatitis C Virus (HCV) – Incorrect HCV is an RNA virus belonging to the Flaviviridae family. It has a single-stranded, positive-sense RNA genome. Transmitted via blood (IV drug use, transfusions), sexual contact, and perinatally. Often leads to chronic infection, increasing the risk of cirrhosis and hepatocellular carcinoma. No vaccine is available, but direct-acting antiviral (DAA) therapy can cure HCV. (D) Hepatitis D Virus (HDV) – Incorrect HDV is an RNA virus, but it is a defective virus that requires HBV coinfection to replicate. It has a single-stranded, circular RNA genome. HDV increases the severity of HBV infection, leading to a higher risk of fulminant hepatitis, cirrhosis, and liver failure. Preventable by the Hepatitis B vaccine, as HDV depends on HBV.",
      "correct_choice_id": 212189,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62278181700905483/62278181700905483.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62278181700905483/62278181700905483.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96960,
      "choices": [
        {
          "id": 212192,
          "text": "Presence of HbeAg in serum"
        },
        {
          "id": 212193,
          "text": "Presence of IgM Anti-Hbc in serum"
        },
        {
          "id": 212194,
          "text": "Presence HbsAg in serum"
        },
        {
          "id": 212195,
          "text": "Presence of IgG anti-HBc in serum"
        }
      ],
      "text": "Early diagnosis of acute hepatitis-B infection is made by:",
      "unique_key": "Q5193380",
      "question_audio": null,
      "question_video": null,
      "map_id": 34515306,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Presence of IgM Anti-HBc in Serum Explanation of the Correct Answer: The earliest marker for acute Hepatitis B infection is IgM anti-HBc (Hepatitis B core antibody, IgM subtype). IgM anti-HBc appears in the early phase of infection and remains detectable for several months, making it the best indicator of acute or recent infection. It is present even during the \"window period\" (when HBsAg disappears but anti-HBs has not yet appeared), making it more reliable than HBsAg alone. Pathogenesis: IgM anti-HBc is a marker of the host immune response to the HBV core antigen (HBcAg). Its presence suggests recent viral replication and ongoing infection. Thus, IgM anti-HBc is the most reliable marker for the early diagnosis of acute Hepatitis B infection. Explanation of Incorrect Options: (A) Presence of HBeAg in Serum – Incorrect HBeAg (Hepatitis B e Antigen) is a marker of active viral replication and high infectivity rather than early diagnosis. Appears after HBsAg but does not confirm acute infection, as it can also be present in chronic carriers. Not a definitive marker for acute hepatitis B diagnosis. (C) Presence of HBsAg in Serum – Incorrect HBsAg (Hepatitis B surface antigen) is the first detectable marker of HBV infection, appearing 2-6 weeks after exposure. However, it cannot distinguish between acute and chronic infection. In some cases, HBsAg may disappear before symptoms appear, making it less reliable than IgM anti-HBc for early diagnosis. (D) Presence of IgG Anti-HBc in Serum – Incorrect IgG anti-HBc appears later in the infection and remains for life, indicating past infection or chronic HBV infection. It is not useful for early diagnosis because it does not differentiate between acute and resolved infections. IgM (not IgG) anti-HBc is the key marker for acute infection.",
      "correct_choice_id": 212193,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62191701700905701/62191701700905701.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62191701700905701/62191701700905701.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96961,
      "choices": [
        {
          "id": 212196,
          "text": "HBeAg"
        },
        {
          "id": 212197,
          "text": "HBV-DNA"
        },
        {
          "id": 212198,
          "text": "HBsAg"
        },
        {
          "id": 212199,
          "text": "Anti-HBc IgM"
        }
      ],
      "text": "All of the following may be present in chronic HBV infection except",
      "unique_key": "Q3592489",
      "question_audio": null,
      "question_video": null,
      "map_id": 34385526,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Anti-HBc IgM. In chronic HBV (Hepatitis B virus) infection, IgM antibodies against hepatitis B core antigen (Anti-HBc IgM) are typically absent or present at very low levels. This marker is primarily associated with acute HBV infection, appearing early during infection and usually declining within six months. In contrast, Anti-HBc IgG remains positive in both acute and chronic infections, serving as a marker of past or ongoing HBV infection. Therefore, the presence of Anti-HBc IgM suggests acute or recent infection rather than chronic HBV infection, making it the correct exception. Explanation of Incorrect Options: (A) HBeAg – Correct Hepatitis B e-antigen (HBeAg) is often present in chronic HBV infection, especially in the immune-tolerant and immune-active phases. It indicates high viral replication and infectivity. However, in the inactive carrier or HBeAg-negative chronic infection phase, HBeAg may not be detectable. (B) HBV-DNA – Correct HBV-DNA is a direct marker of viral replication and is present in chronic HBV infection, though its levels vary depending on the phase of infection. Higher HBV-DNA levels indicate active viral replication, while lower levels suggest an inactive carrier state. (C) HBsAg – Correct Hepatitis B surface antigen (HBsAg) is a hallmark of chronic HBV infection. It is persistently present in the blood for more than six months in chronic cases. Its persistence indicates an ongoing HBV infection, with or without active liver disease.",
      "correct_choice_id": 212199,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3182761700906032/3182761700906032.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3182761700906032/3182761700906032.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96962,
      "choices": [
        {
          "id": 212200,
          "text": "HCV belongs to flavivirus"
        },
        {
          "id": 212201,
          "text": "No vaccine available for Hepatitis E"
        },
        {
          "id": 212202,
          "text": "HBV is a DNA virus"
        },
        {
          "id": 212203,
          "text": "HDV is defective virus"
        }
      ],
      "text": "All of the following is true except",
      "unique_key": "Q9598880",
      "question_audio": null,
      "question_video": null,
      "map_id": 34610950,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) No vaccine available for Hepatitis E. This statement is incorrect because a vaccine for Hepatitis E does exist. The HEV 239 (Hecolin) vaccine, based on recombinant HEV capsid protein, has been developed and is licensed in China for the prevention of Hepatitis E. However, it is not widely available globally, and no universal vaccination programs exist for HEV. This makes option B incorrect, as a vaccine is available, albeit with limited distribution. Explanation of Incorrect Options: (A) HCV belongs to Flavivirus – Correct Hepatitis C virus (HCV) is a positive-sense, single-stranded RNA virus classified under the Flaviviridae family, genus Hepacivirus. It shares structural and replication similarities with other flaviviruses, such as Dengue and Yellow Fever viruses. (C) HBV is a DNA virus – Correct Hepatitis B virus (HBV) is a partially double-stranded DNA virus belonging to the Hepadnaviridae family. Unlike other DNA viruses, HBV replicates via reverse transcription, making it unique among DNA viruses. (D) HDV is a defective virus – Correct Hepatitis D virus (HDV) is a defective RNA virus that requires Hepatitis B virus (HBV) for replication. HDV lacks its own surface proteins and depends on HBsAg from HBV to form new viral particles and infect hepatocytes.",
      "correct_choice_id": 212201,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96963,
      "choices": [
        {
          "id": 212204,
          "text": "HBcAb"
        },
        {
          "id": 212205,
          "text": "HBsAb"
        },
        {
          "id": 212206,
          "text": "HBeAb"
        },
        {
          "id": 212207,
          "text": "HBeAb and HBsAb"
        }
      ],
      "text": "An individual who has received all three doses of hepatitis B vaccine and who has never hadhepatitis B virus (HBV) infection would be expected to have which of the following serologicmarker(s)?",
      "unique_key": "Q7031830",
      "question_audio": null,
      "question_video": null,
      "map_id": 34608968,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) HBsAb (Hepatitis B surface antibody). An individual who has received all three doses of the hepatitis B vaccine and has never had hepatitis B virus (HBV) infection would be expected to have HBsAb (anti-HBs) as the only detectable serologic marker. The hepatitis B vaccine is composed of the recombinant HBsAg (hepatitis B surface antigen), which stimulates the immune system to produce protective HBsAb. This antibody provides long-term immunity against HBV by neutralizing the virus upon exposure. However, since the vaccine does not contain core antigens (HBcAg) or e antigens (HBeAg), individuals who are only vaccinated and never infected will not develop antibodies to these antigens. Incorrect options: (A) HBcAb (Hepatitis B core antibody) – Incorrect. HBcAb is produced only in response to natural HBV infection because it forms against the core antigen (HBcAg), which is not included in the vaccine. A vaccinated individual who has never been infected will not have HBcAb. (C) HBeAb (Hepatitis B e antibody) – Incorrect. HBeAb is formed only during or after natural HBV infection as a response to HBeAg, a viral antigen associated with viral replication. Since the vaccine does not contain HBeAg, a vaccinated individual will not develop HBeAb. (D) HBeAb and HBsAb – Incorrect. As explained above, while HBsAb is present due to vaccination, HBeAb is only present in individuals who have had a prior natural infection with HBV. Since a vaccinated person without infection never encounters HBeAg, they will not develop HBeAb.",
      "correct_choice_id": 212205,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77432441700906049/77432441700906049.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77432441700906049/77432441700906049.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96964,
      "choices": [
        {
          "id": 212208,
          "text": "HBsAg"
        },
        {
          "id": 212209,
          "text": "Anti HBsAg"
        },
        {
          "id": 212210,
          "text": "IgM Anti HBcAg"
        },
        {
          "id": 212211,
          "text": "IgM Anti HBeAg"
        }
      ],
      "text": "After vaccination for Hepatitis B the following viral marker should be measured to ascertainwhether the vaccinee is a responder or non responder",
      "unique_key": "Q1411702",
      "question_audio": null,
      "question_video": null,
      "map_id": 34497684,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Anti-HBsAg (Anti-HBs). After Hepatitis B vaccination, the immune system produces antibodies against the Hepatitis B surface antigen (HBsAg), known as Anti-HBs. The presence of Anti-HBs ?10 mIU/mL in serum confirms that the individual has developed immunity and is a vaccine responder. If Anti-HBs levels remain <10 mIU/mL, the person is considered a non-responder and may require revaccination or further evaluation. Anti-HBs is the only serologic marker that indicates successful vaccination, as the vaccine does not contain other viral components. Incorrect options: (A) HBsAg – Incorrect. HBsAg (Hepatitis B surface antigen) is present only in active Hepatitis B infection and is not found in vaccinated individuals. Testing for HBsAg after vaccination is meaningless because the vaccine does not contain live virus; it only contains the HBsAg component, which stimulates immunity. (C) IgM Anti-HBcAg – Incorrect. IgM Anti-HBcAg (IgM antibody to Hepatitis B core antigen) appears in acute Hepatitis B infection and is not produced in response to vaccination. Since the Hepatitis B vaccine does not contain the core antigen (HBcAg), vaccinated individuals will be negative for Anti-HBc. (D) IgM Anti-HBeAg – Incorrect. IgM Anti-HBeAg (antibody to Hepatitis B e antigen) is a marker of recent or resolving infection but is not associated with vaccination. HBeAg and its antibodies play a role in viral replication and infectivity, but they are not relevant to assessing vaccine response.",
      "correct_choice_id": 212209,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67852351700906174/67852351700906174.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67852351700906174/67852351700906174.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96965,
      "choices": [
        {
          "id": 212212,
          "text": "Hepatitis B vaccine + immunoglobulins"
        },
        {
          "id": 212213,
          "text": "Immunoglobulins"
        },
        {
          "id": 212214,
          "text": "Hepatitis B vaccine only"
        },
        {
          "id": 212215,
          "text": "Immunoglobulin followed by vaccine 1 month later"
        }
      ],
      "text": "A mother is HBsAg positive at 32 weeks of pregnancy. What should be given to the newborn toprevent neonatal infection",
      "unique_key": "Q5188343",
      "question_audio": null,
      "question_video": null,
      "map_id": 34070108,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hepatitis B vaccine + immunoglobulins. If a mother is HBsAg-positive during pregnancy, her newborn is at high risk of acquiring perinatal (vertical) Hepatitis B infection, especially if she is also HBeAg-positive, which indicates high viral replication and infectivity. To prevent neonatal infection, the baby should receive: Hepatitis B vaccine (active immunity) – Given within 12 hours of birth, followed by the complete vaccine series at 1, 2, and 6 months. Hepatitis B Immunoglobulin (HBIG) (passive immunity) – Also given within 12 hours of birth, preferably at a different site from the vaccine. HBIG provides immediate protection while the vaccine helps the baby develop long-term immunity. This combination reduces the risk of neonatal infection to less than 1%, whereas without prophylaxis, the risk of chronic Hepatitis B infection in exposed neonates is 90%. Incorrect options: (B) Immunoglobulins only – Incorrect. HBIG provides only short-term passive immunity, which wanes over time. Without the Hepatitis B vaccine, the infant would lack long-term protection, leaving them vulnerable to infection later in life. (C) Hepatitis B vaccine only – Incorrect. While the Hepatitis B vaccine is essential, it takes weeks to months for the baby to develop adequate immunity. Without HBIG, the newborn remains susceptible to immediate infection from maternal exposure. (D) Immunoglobulin followed by vaccine 1 month later – Incorrect. Delaying the Hepatitis B vaccine increases the risk of early transmission, as the baby lacks active immunity during the first crucial weeks of life. The vaccine must be given immediately at birth alongside HBIG.",
      "correct_choice_id": 212212,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48442671700906192/48442671700906192.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48442671700906192/48442671700906192.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96966,
      "choices": [
        {
          "id": 212216,
          "text": "In low-endemicity regions, vaccination is only for high-risk individuals"
        },
        {
          "id": 212217,
          "text": "In intermediate-endemicity regions, vaccination is required"
        },
        {
          "id": 212218,
          "text": "In high-endemicity regions, vaccination is not required"
        },
        {
          "id": 212219,
          "text": "Anti-HAV antibody testing has no role in determining vaccination"
        }
      ],
      "text": "For Hepatitis A vaccination all are true except",
      "unique_key": "Q3783650",
      "question_audio": null,
      "question_video": null,
      "map_id": 34940056,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Anti-HAV antibody testing has no role in determining vaccination. Anti-HAV antibody testing (to detect pre-existing immunity) is sometimes recommended before vaccination, especially in older individuals or in high-endemicity regions, where many people have already been exposed to Hepatitis A virus (HAV) and developed natural immunity. Since vaccination is only needed for susceptible individuals, pre-vaccination testing may help avoid unnecessary vaccination. Therefore, the statement that \"Anti-HAV antibody testing has no role\" is incorrect. Incorrect options: (A) In low-endemicity regions, vaccination is only for high-risk individuals – Correct. In regions with low HAV endemicity, exposure to Hepatitis A virus is rare, and most people remain susceptible. Routine vaccination is not required for the general population, but it is recommended for high-risk groups, such as: Travelers to endemic areas Healthcare workers Individuals with chronic liver disease Men who have sex with men (MSM) (B) In intermediate-endemicity regions, vaccination is required – Correct. In intermediate-endemicity regions, HAV transmission is moderate, and many infections occur during adolescence or adulthood, when the disease tends to be more severe. Routine childhood vaccination is recommended to prevent outbreaks and long-term transmission. (C) In high-endemicity regions, vaccination is not required – Correct. In regions with high HAV endemicity, most people are infected in early childhood, when the disease is usually asymptomatic or mild. Since natural immunity is widespread, routine vaccination is not necessary, as very few people remain susceptible in adulthood.",
      "correct_choice_id": 212219,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57666381700906261/57666381700906261.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57666381700906261/57666381700906261.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96967,
      "choices": [
        {
          "id": 212220,
          "text": "HBsAg"
        },
        {
          "id": 212221,
          "text": "Anti HBsAg"
        },
        {
          "id": 212222,
          "text": "IgG anti HBc"
        },
        {
          "id": 212223,
          "text": "IgM anti HBc"
        }
      ],
      "text": "The marker to detect superinfection of Hepatitis D in Hepatitis B patient is",
      "unique_key": "Q8026320",
      "question_audio": null,
      "question_video": null,
      "map_id": 34185361,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) IgG anti-HBc. Hepatitis D virus (HDV) requires Hepatitis B virus (HBV) for replication. When HDV infects an individual already chronically infected with HBV, it is termed superinfection (as opposed to co-infection, where both viruses are acquired simultaneously). IgG anti-HBc (Hepatitis B core antibody, IgG type) is a marker of past or chronic HBV infection and remains positive for life in chronic HBV patients. Since HDV superinfection occurs in chronic HBV carriers, the presence of IgG anti-HBc confirms the chronic HBV status, making it a key indicator for distinguishing superinfection from acute HBV infections. Incorrect options: (A) HBsAg (Hepatitis B surface antigen) – Incorrect. While HBsAg is an indicator of an active HBV infection, it does not distinguish between HBV monoinfection and HDV superinfection. It remains positive in both cases, so it is not a reliable marker for identifying superinfection specifically. (B) Anti-HBsAg (Hepatitis B surface antibody) – Incorrect. Anti-HBs is a marker of recovery from HBV infection or successful vaccination. However, chronic HBV patients (who can get HDV superinfection) do not develop anti-HBs because the virus continues to produce HBsAg. Since superinfection occurs in those who are already HBsAg-positive, anti-HBs would not be present. (D) IgM anti-HBc (IgM antibody to HBV core antigen) – Incorrect. IgM anti-HBc is a marker of acute HBV infection and is seen in recent infections (either acute HBV or HBV-HDV co-infection). However, superinfection occurs in chronic HBV carriers, who generally have IgG anti-HBc rather than IgM anti-HBc.",
      "correct_choice_id": 212222,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11849031700906378/11849031700906378.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11849031700906378/11849031700906378.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96968,
      "choices": [
        {
          "id": 212224,
          "text": "Chronic hepatitis B infection with high infectivity"
        },
        {
          "id": 212225,
          "text": "Acute hepatitis B infection with high infectivity"
        },
        {
          "id": 212226,
          "text": "Chronic hepatitis B infection with low infectivity"
        },
        {
          "id": 212227,
          "text": "Acute hepatitis B infection with low infectivity"
        },
        {
          "id": 212228,
          "text": "Acute hepatitis B infection with low infectivity"
        }
      ],
      "text": "Thirty year old man presented with nausea, fever and jaundice of 5 days duration. Thebiochemical tests revealed a bilirubin of 6.7 mg/dl (conjugated 5.0 mg/dl) with SGOT/SGPT(AST/ALT) of 1230/900 IU/ml. The serological tests showed the presence of HBsAg, IgM anti HBcand HBeAg. The most likely diagnosis is",
      "unique_key": "Q7138005",
      "question_audio": null,
      "question_video": null,
      "map_id": 34573591,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Acute hepatitis B infection with high infectivity. This 30-year-old man presents with nausea, fever, and jaundice, which are typical symptoms of acute viral hepatitis. His biochemical tests show elevated bilirubin (predominantly conjugated), high AST/ALT levels (>1000 IU/ml), and positive serological markers for active hepatitis B infection. Key serological findings: HBsAg (Hepatitis B surface antigen) – Indicates active HBV infection. IgM anti-HBc (IgM antibody to Hepatitis B core antigen) – Confirms acute HBV infection. IgM anti-HBc is the earliest antibody marker to appear in acute infection. HBeAg (Hepatitis B e antigen) – Indicates high viral replication and infectivity. Since the patient has positive IgM anti-HBc, it confirms acute hepatitis B infection. The presence of HBeAg suggests high infectivity because this antigen is associated with active viral replication and increased transmission risk. Incorrect Options: (A) Chronic hepatitis B infection with high infectivity – Incorrect Chronic HBV infection is diagnosed when HBsAg persists for more than 6 months. This patient has only 5 days of symptoms, making acute infection more likely. IgM anti-HBc is seen in acute infection, whereas chronic infection typically shows IgG anti-HBc. (C) Chronic hepatitis B infection with low infectivity – Incorrect As stated above, chronic HBV infection is not diagnosed within a short symptomatic duration. Moreover, low infectivity in chronic infection is indicated by negative HBeAg and positive anti-HBe, which is not the case here. (D) Acute hepatitis B infection with low infectivity – Incorrect Acute infection with low infectivity is indicated when HBeAg is absent and anti-HBe is positive. In this case, HBeAg is present, confirming high infectivity.",
      "correct_choice_id": 212225,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19252391700906465/19252391700906465.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19252391700906465/19252391700906465.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96969,
      "choices": [
        {
          "id": 212229,
          "text": "Acute hepatitis B disease"
        },
        {
          "id": 212230,
          "text": "Chronic hepatitis B disease"
        },
        {
          "id": 212231,
          "text": "Chronic hepatitis B disease with hepatitis D superinfection"
        },
        {
          "id": 212232,
          "text": "Acute hepatitis D disease"
        }
      ],
      "text": "A patient suffering from hepatitis underwent a batteryof laboratory tests to determine the cause of the disease.The following results were obtained from serologicaland biochemical testing of the patients serum:HBsAg positive, HBeAg positive, anti-HBcAg IgMpositive, anti-HBsAg negative, HDV RNA negative,elevated liver enzymes. From these results, howwould you diagnose this patient's infection?",
      "unique_key": "Q5612415",
      "question_audio": null,
      "question_video": null,
      "map_id": 34647408,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct answer (A) Acute hepatitis B disease. Based on the test results provided, the diagnosis of acute hepatitis B disease is the most likely. Here's why: HBsAg positive indicates that the patient has an active hepatitis B infection (the surface antigen of the hepatitis B virus). HBeAg positive suggests active viral replication and a higher level of infectivity. Anti-HBcAg IgM positive is a marker of acute infection with hepatitis B, as IgM antibodies are produced during the initial response to the infection. Anti-HBsAg negative indicates the absence of protective immunity (the person has not yet developed antibodies against the surface antigen). The elevated liver enzymes suggest active liver damage, which is consistent with acute hepatitis. These results point to acute hepatitis B, as there is active viral replication (HBeAg positive), and the presence of IgM antibodies against the core antigen (anti-HBcAg IgM) indicates that the infection is in the acute phase. Incorrect Options: (B) Chronic hepatitis B disease Chronic hepatitis B would typically show HBsAg positive for more than 6 months and may have anti-HBe antibodies (anti-HBe positive) if the patient has transitioned to a non-replicative phase. The patient's IgM anti-HBc and elevated liver enzymes suggest acute, rather than chronic, disease. (C) Chronic hepatitis B disease with hepatitis D superinfection In this case, HDV RNA negative rules out a hepatitis D infection. Hepatitis D only occurs in the presence of chronic hepatitis B, and this patient’s lab results do not show any evidence of hepatitis D. (D) Acute hepatitis D disease The absence of HDV RNA means that the patient is not infected with hepatitis D, which is required for a diagnosis of acute hepatitis D. Hepatitis D infection only occurs in individuals already infected with hepatitis B, and there is no evidence of HDV RNA in this patient.",
      "correct_choice_id": 212229,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69704551701070589/69704551701070589.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69704551701070589/69704551701070589.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96970,
      "choices": [
        {
          "id": 212233,
          "text": "Hepatitis B vaccine consists of two IM doses 1 month apart."
        },
        {
          "id": 212234,
          "text": "Only patients with defined risk factors need to be vaccinated"
        },
        {
          "id": 212235,
          "text": "Pregnancy is not a contraindication to the hepatitis B vaccine"
        },
        {
          "id": 212236,
          "text": "This patient’s hepatitis serologies should be checked before vaccination."
        }
      ],
      "text": "A 26-year-old woman presents to your clinic and is interested in getting pregnant. She seeks your advice regarding vaccines she should obtain, and in particular asks about the hepatitis B vaccine. She works as a receptionist for a local business, denies alcohol or illicit drug use, and is in a monogamous relationship. Which of the following is true regarding hepatitis B vaccination?",
      "unique_key": "Q3127588",
      "question_audio": null,
      "question_video": null,
      "map_id": 34777015,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Pregnancy is not a contraindication to the hepatitis B vaccine. Explanation for the Correct Answer: Hepatitis B vaccination is safe during pregnancy and is recommended for pregnant women who are at risk of hepatitis B virus (HBV) infection. The hepatitis B vaccine is an inactivated (recombinant) vaccine, meaning it does not contain live virus and poses no risk to the developing fetus. Pregnant women who are not immune to HBV should be vaccinated to prevent infection and reduce the risk of maternal-to-child transmission, which can lead to chronic hepatitis B in the newborn. The Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) support hepatitis B vaccination in pregnancy. Explanation for Incorrect Answers: (A) Hepatitis B vaccine consists of two IM doses 1 month apart. Incorrect. The standard hepatitis B vaccination schedule consists of three intramuscular (IM) doses: First dose (initial) Second dose (1 month after the first dose) Third dose (6 months after the first dose) There is also an accelerated schedule (0, 1, and 2 months + a booster at 12 months) for high-risk individuals, but the standard vaccine schedule includes three doses, not two. (B) Only patients with defined risk factors need to be vaccinated. Incorrect. While individuals at higher risk (e.g., healthcare workers, IV drug users, people with multiple sexual partners) should be prioritized, universal vaccination is recommended for all infants, unvaccinated adults, and anyone seeking protection against HBV. Hepatitis B virus can be asymptomatic and spread unknowingly, so relying solely on risk factors for vaccination misses many cases. (D) This patient’s hepatitis serologies should be checked before vaccination. Incorrect. Routine pre-vaccination hepatitis serology testing is not required unless the individual is at higher risk (e.g., healthcare workers, individuals born in high-endemic countries). In this case, since the patient does not have known risk factors and is interested in vaccination, she can proceed with vaccination without serologic testing. However, if she were in a high-risk group, testing for HBsAg (active infection), anti-HBs (immunity), and anti-HBc (past infection) might be considered.",
      "correct_choice_id": 212235,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33146951701071162/33146951701071162.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33146951701071162/33146951701071162.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96971,
      "choices": [
        {
          "id": 212237,
          "text": "As he is infected with genotype 1, the likelihood of response to pegylated interferon and ribavirin is less than 40%."
        },
        {
          "id": 212238,
          "text": "Following 12 weeks of treatment, the expected viral load should be undetectable."
        },
        {
          "id": 212239,
          "text": "Given his normal liver enzymes on laboratory testing, he is unlikely to develop progressive liver injury."
        },
        {
          "id": 212240,
          "text": "The presence of bridging fibrosis on liver biopsy is the most predictive factor of the development of cirrhosis over the next 10–20 years."
        }
      ],
      "text": "A 46-year-old man is known to have chronic hepatitis C virus (HCV) infection. He is a former IV drug user for more than 20 years who has been abstinent from drug use for 1 year. He is asking whether he should receive treatment for his HCV infection. He has a prior history of hepatitis B virus (HBV) and has positive antibody to HBV surface antigen. He was treated for tricuspid valve endocarditis 3 years previously. He has no other medical history. He does not know when he acquired HCV. His laboratory studies show a positive HCV IgG antibody with a viral load of greater than 1 million copies. The virus is genotype 1. His AST is 62 U/L, and his ALT is 54 U/L. He undergoes liver biopsy, which demonstrates a moderate degree of bridging fibrosis. What do you tell him regarding his likelihood of progression and possibilities regarding treatment?",
      "unique_key": "Q9332682",
      "question_audio": null,
      "question_video": null,
      "map_id": 34332365,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) The presence of bridging fibrosis on liver biopsy is the most predictive factor of the development of cirrhosis over the next 10–20 years. Explanation for the Correct Answer: Bridging fibrosis on liver biopsy is indeed a strong predictor of progression to cirrhosis and is one of the most important factors in determining prognosis for patients with chronic hepatitis C. Bridging fibrosis indicates the development of significant liver scarring, where fibrosis has started to link two or more portal tracts or central veins, which can ultimately lead to cirrhosis. Patients with bridging fibrosis have a higher risk of progressing to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) over the course of the next 10–20 years. Therefore, treatment to prevent further progression of liver damage, such as antiviral therapy, is strongly recommended for patients with this level of liver damage. Explanation for Incorrect Answers: (A) As he is infected with genotype 1, the likelihood of response to pegylated interferon and ribavirin is less than 40%. Incorrect. While genotype 1 (especially 1a) was traditionally associated with a lower response rate to pegylated interferon and ribavirin, direct-acting antiviral (DAA) therapy has significantly improved treatment outcomes. The response rate to DAA regimens for genotype 1 HCV can be greater than 90%. The old statistics regarding response to interferon and ribavirin are no longer applicable with current treatment options. (B) Following 12 weeks of treatment, the expected viral load should be undetectable. Incorrect. The goal of HCV treatment is sustained virological response (SVR), which is defined as undetectable HCV RNA 12 weeks after the completion of therapy (SVR12). However, the time to undetectable viral load may vary depending on the treatment regimen and the genotype of the virus. For most patients on modern DAA regimens, viral load will often become undetectable within the first 4-6 weeks of treatment, but SVR is the key metric, and achieving this does not always guarantee an undetectable viral load within 12 weeks. (C) Given his normal liver enzymes on laboratory testing, he is unlikely to develop progressive liver injury. Incorrect. Although the patient’s AST and ALT levels are elevated, they are not significantly high and could still be in the normal range during periods of HCV infection. However, normal liver enzymes do not exclude the presence of significant liver damage. In fact, many patients with chronic hepatitis C may have normal or mildly elevated liver enzymes even with advanced fibrosis or cirrhosis. Liver biopsy showing bridging fibrosis is a more important predictor of liver disease progression than enzyme levels alone.",
      "correct_choice_id": 212240,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96972,
      "choices": [
        {
          "id": 212241,
          "text": "Hepatitis A virus."
        },
        {
          "id": 212242,
          "text": "Hepatitis B virus."
        },
        {
          "id": 212243,
          "text": "Hepatitis C virus."
        },
        {
          "id": 212244,
          "text": "Hepatitis D virus."
        }
      ],
      "text": "A company held an elaborate holiday dinner party forits 42 employees. Within 3 to 4 weeks, many of thebanquet attendees complained of experiencingfatigue, fever, nausea, and dark urine and wereobserved to be jaundiced. The group exhibited nobacterial infections in common. The employees whobecame ill had all eaten raw oysters at the party. Thecompany doctor assayed a sample of the employees’blood for anti-hepatitis B antibodies, but all sampleswere negative for anti-hepatitis B surface antigenimmunoglobulin M. The causative agent consistentwith this history is most likely:",
      "unique_key": "Q3040437",
      "question_audio": null,
      "question_video": null,
      "map_id": 34730565,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct answer (A) Hepatitis A virus. Explanation for the Correct Answer: The most likely causative agent in this case is Hepatitis A virus (HAV). The group of employees developed symptoms of fatigue, fever, nausea, dark urine, and jaundice after a holiday dinner party, and it is significant that they all consumed raw oysters, a common source of HAV. Hepatitis A is an acute viral infection transmitted primarily through the fecal-oral route, often associated with contaminated food or water. The virus can also be found in shellfish harvested from contaminated waters. The absence of anti-hepatitis B antibodies and the timing of the symptoms further supports the diagnosis of Hepatitis A, as Hepatitis A does not cause chronic infection, unlike Hepatitis B. Explanation for Incorrect Answers: (B) Hepatitis B virus. Incorrect. Hepatitis B virus (HBV) is typically transmitted through blood, sexual contact, or perinatal exposure, not through the consumption of contaminated food or water. The patient's negative anti-HBV surface antigen immunoglobulin M (IgM) test result also indicates that hepatitis B is not the cause. Additionally, hepatitis B usually results in chronic infection, unlike hepatitis A, which is acute and self-limiting. (C) Hepatitis C virus. Incorrect. Hepatitis C virus (HCV) is primarily transmitted through blood-to-blood contact, particularly via intravenous drug use or transfusions with non-screened blood. It is not typically spread through food consumption. The symptoms in this case are more consistent with Hepatitis A rather than Hepatitis C, especially in the context of the recent raw oyster consumption. (D) Hepatitis D virus. Incorrect. Hepatitis D virus (HDV) is a defective virus that only occurs in individuals who are already infected with hepatitis B virus (HBV). This patient's negative hepatitis B serologies make Hepatitis D an unlikely cause of illness.",
      "correct_choice_id": 212241,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18936531701071210/18936531701071210.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18936531701071210/18936531701071210.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96973,
      "choices": [
        {
          "id": 212245,
          "text": "Chronic hepatitis"
        },
        {
          "id": 212246,
          "text": "Fetal hydrops"
        },
        {
          "id": 212247,
          "text": "Fulminant hepatic failure"
        },
        {
          "id": 212248,
          "text": "Guillain–Barré syndrome"
        }
      ],
      "text": "An outbreak of hepatitis occurred in a slum area of Mumbai with poor sanitation. Most of the patients reported fever, nausea with vomiting, and weight loss occurring over several days followed by jaundice and pruritus. Testing quickly ruled out HAV. A number of women in the area are pregnant. For which of the following are these women at risk?",
      "unique_key": "Q8577957",
      "question_audio": null,
      "question_video": null,
      "map_id": 34706567,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) The most likely cause of this hepatitis outbreak in a slum area with poor sanitation is Hepatitis E virus (HEV), particularly HEV genotype 1 or 2, which are transmitted via the fecal-oral route through contaminated water. The clinical presentation—fever, nausea, vomiting, weight loss, jaundice, and pruritus—is consistent with acute viral hepatitis. While HEV generally causes a self-limiting infection, pregnant women are at significant risk of developing fulminant hepatic failure due to severe liver necrosis, massive hepatocyte apoptosis, and hepatic encephalopathy. Pregnant women, especially those in the third trimester, have a higher mortality rate (~20-25%) from HEV infection due to hormonal and immune changes that make them more susceptible to severe liver injury. Fulminant hepatic failure in these cases can lead to disseminated intravascular coagulation (DIC), multi-organ failure, and maternal or fetal death. Incorrect Options: (A) Chronic Hepatitis – Incorrect. Unlike Hepatitis B (HBV) and Hepatitis C (HCV), which frequently progress to chronic infection, HEV is usually an acute and self-limiting illness. Chronic HEV infection occurs only in immunocompromised individuals (e.g., organ transplant recipients, HIV patients) but not in healthy pregnant women. (B) Fetal Hydrops – Incorrect. Fetal hydrops (hydrops fetalis) is a condition characterized by abnormal fluid accumulation in fetal compartments (pleural effusion, ascites, pericardial effusion, skin edema) and is commonly associated with parvovirus B19 infection, Rh incompatibility, or congenital heart defects. HEV does not cause hydrops fetalis, although maternal HEV infection can lead to miscarriage or stillbirth due to fulminant hepatic failure. (D) Guillain–Barré Syndrome (GBS) – Incorrect. GBS is an autoimmune-mediated acute polyneuropathy, often triggered by infections such as Campylobacter jejuni, Cytomegalovirus (CMV), Epstein-Barr virus (EBV), or Mycoplasma pneumoniae. While some rare neurological complications of HEV (e.g., Guillain–Barré syndrome, neuralgic amyotrophy) have been reported, they are not a primary risk for pregnant women and are far less common than fulminant hepatic failure.",
      "correct_choice_id": 212247,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59245641700992588/59245641700992588.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59245641700992588/59245641700992588.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96974,
      "choices": [
        {
          "id": 212249,
          "text": "A hepatitis B mutant has developed"
        },
        {
          "id": 212250,
          "text": "He has contracted hepatitis D virus (HDV)"
        },
        {
          "id": 212251,
          "text": "He has developed cirrhosis"
        },
        {
          "id": 212252,
          "text": "His food contained hepatitis A virus (HAV)"
        }
      ],
      "text": "A 29-year-old intravenous (IV) drug abuser who is a known case of chronic hepatitis B virus (HBV) status suddenly presents with an acute hepatitis episode. He develops massive hepatic necrosis and even after best medical efforts he dies. Which of the following is most likely responsible for the change in his condition?",
      "unique_key": "Q9546090",
      "question_audio": null,
      "question_video": null,
      "map_id": 34479140,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) He has contracted hepatitis D virus (HDV) The most likely cause of this patient's acute worsening of hepatitis B infection with massive hepatic necrosis is superinfection with hepatitis D virus (HDV). HDV is a defective RNA virus that requires the HBsAg (hepatitis B surface antigen) from HBV for its replication and transmission. Superinfection of an HBV carrier with HDV leads to severe, rapidly progressive liver disease, often resulting in fulminant hepatitis with massive hepatic necrosis, as seen in this case. IV drug users are at high risk for HDV due to shared needles and blood exposure. In HDV superinfection, the preexisting chronic HBV infection cannot mount an adequate immune response, leading to rapid liver damage and high mortality. This explains why the patient suddenly deteriorated despite chronic HBV status and succumbed to liver failure. Incorrect Options: (A) A hepatitis B mutant has developed – Incorrect. HBV mutants, such as the precore mutant, can cause severe disease progression, but they do not typically cause fulminant hepatic necrosis. HBV mutations can lead to a more aggressive course, but they would not explain the sudden and severe liver failure seen in this case. HDV superinfection is a much more likely cause. (C) He has developed cirrhosis – Incorrect. While cirrhosis is a complication of chronic HBV, it is a gradual process occurring over years rather than causing an acute, fulminant presentation. Cirrhosis increases the risk of hepatocellular carcinoma (HCC) and portal hypertension, but it would not cause sudden hepatic necrosis. (D) His food contained hepatitis A virus (HAV) – Incorrect. Hepatitis A virus (HAV) is transmitted via the fecal-oral route and causes self-limiting acute hepatitis, but it does not cause chronic liver disease or massive hepatic necrosis in an otherwise healthy person. Though HAV can worsen preexisting liver disease, it is not the most likely cause of fulminant hepatic failure in this scenario.",
      "correct_choice_id": 212250,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29221581700992723/29221581700992723.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29221581700992723/29221581700992723.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96975,
      "choices": [
        {
          "id": 212253,
          "text": "HBsAg +, HBeAg +, Anti-HBcAg IgM +, Anti-HBcAg IgG -, Anti-HBsAg -"
        },
        {
          "id": 212254,
          "text": "HBsAg +, HBeAg +, Anti-HBcAg IgM -, Anti-HBcAg IgG +, Anti-HBsAg -"
        },
        {
          "id": 212255,
          "text": "HBsAg -, HBeAg -, Anti-HBcAg IgM -, Anti-HBcAg IgG +, Anti-HBsAg +"
        },
        {
          "id": 212256,
          "text": "HBsAg -, HBeAg -, Anti-HBcAg IgM -, Anti-HBcAg IgG -, Anti-HBsAg +"
        }
      ],
      "text": "A street person well known to the local public health clinic appears to have acute symptoms of hepatitis and tests positive for HDV antigen. Knowing that HDV requires HBV, which of the following sets of test results shows this patient had chronic HBV infection and was superinfected with HDV?",
      "unique_key": "Q6072179",
      "question_audio": null,
      "question_video": null,
      "map_id": 34094869,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) This patient has tested positive for HDV antigen, which indicates hepatitis D virus (HDV) infection. Since HDV requires hepatitis B virus (HBV) for replication, this means the patient must have an existing HBV infection. The distinguishing feature of HDV superinfection (when HDV infects a person already chronically infected with HBV) is that the patient already has chronic HBV markers. The serologic profile in option B shows: HBsAg (+) Indicates an active HBV infection (since the surface antigen is present). HBeAg (+) Suggests high HBV replication and infectivity. Anti-HBc IgM (-) and Anti-HBc IgG (+) The absence of IgM and the presence of IgG indicate a chronic HBV infection rather than an acute one. In acute HBV, IgM would be positive. Anti-HBs (-) Shows that the patient has not developed immunity (either through recovery or vaccination), which supports chronic HBV infection. Since the patient has chronic HBV (indicated by IgG anti-HBc positivity and HBsAg positivity), and now has acute hepatitis symptoms with HDV antigen positivity, this is a case of HDV superinfection on top of chronic HBV. Explanation of Incorrect Options: Option A: HBsAg (+), HBeAg (+), Anti-HBc IgM (+), Anti-HBc IgG (-), Anti-HBs (-) The presence of IgM anti-HBc suggests acute HBV infection rather than chronic HBV. HDV superinfection occurs in those with chronic HBV, not acute infection. Since this patient has HDV superinfection, they must already have a chronic HBV infection, making this option incorrect. Option C: HBsAg (-), HBeAg (-), Anti-HBc IgM (-), Anti-HBc IgG (+), Anti-HBs (+) Anti-HBc IgG (+) and Anti-HBs (+) indicate past HBV infection with recovery. Since HBsAg is negative, there is no active HBV infection, which means HDV cannot be present (HDV requires HBV). This contradicts the case scenario, making this option incorrect. Option D: HBsAg (-), HBeAg (-), Anti-HBc IgM (-), Anti-HBc IgG (-), Anti-HBs (+) Anti-HBs (+) but no Anti-HBc IgG suggests the patient was vaccinated against HBV but was never infected. Since HBsAg is negative, there is no current HBV infection, and therefore HDV infection is not possible. This directly contradicts the presence of HDV antigen, making the option incorrect.",
      "correct_choice_id": 212254,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/9919981700993117/9919981700993117.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/9919981700993117/9919981700993117.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96976,
      "choices": [
        {
          "id": 212257,
          "text": "Has a biologic false-positive test for hepatitis"
        },
        {
          "id": 212258,
          "text": "Is highly contagious"
        },
        {
          "id": 212259,
          "text": "Is less contagious"
        },
        {
          "id": 212260,
          "text": "Is not contagious"
        }
      ],
      "text": "A labourer working in the biomedical waste management facility of a hospital is found to be positive for hepatitis B surface antigen. Subsequent tests reveal the presence of HBeAg as well. Which of the following best describes the worker?",
      "unique_key": "Q1308432",
      "question_audio": null,
      "question_video": null,
      "map_id": 34002624,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Is highly contagious: This worker tested positive for HBsAg (Hepatitis B surface antigen) and HBeAg (Hepatitis B e antigen). The presence of HBsAg indicates an active HBV infection, meaning the virus is replicating in the body. The presence of HBeAg is particularly significant because it is associated with high viral replication and increased infectivity. HBeAg is a marker of active viral replication, meaning the person has a high viral load and is highly contagious to others through blood and bodily fluids (e.g., via needlestick injuries, mucosal exposure, or sexual contact). Workers handling biomedical waste in a hospital setting are at higher risk of transmitting the virus to others if proper protective measures (gloves, hand hygiene, vaccinations) are not followed. Explanation of Incorrect Options: Option A: Has a biologic false-positive test for hepatitis A biologic false-positive means that the test incorrectly detects HBV when the person does not actually have the infection. Since the worker tested positive for both HBsAg and HBeAg, this confirms an active infection rather than a false positive. A false-positive result would be more likely in cases with isolated HBsAg positivity without additional markers. Option C: Is less contagious HBeAg-negative individuals tend to have lower levels of viral replication and are less contagious. However, this worker has HBeAg positivity, which indicates high infectivity, making this statement incorrect. Option D: Is not contagious HBsAg-positive individuals are always considered contagious as long as they remain positive. The presence of HBeAg further confirms high viral replication, making the worker extremely contagious. Saying the worker is not contagious contradicts the presence of both HBsAg and HBeAg, making this option completely incorrect.",
      "correct_choice_id": 212258,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69799641700993139/69799641700993139.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69799641700993139/69799641700993139.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}